Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Projects.
  • Patent applications/Patents.
  • Presentations.
  • Advised theses.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Trauner Michael |

Presentations at scientific and public conferences

Fuchs, C; Petrenko, O; Mlitz, V; Scharnagl, H; Stojakovic, T; Reiberger, T; Garfinkel, B; Trauner, M Inhibition of bile acid conjugation improves DDC-induced cholestatic liver injury in mice with a humanized bile acid pool
J HEPATOL. Abstracts. 2024; 80: S296-S296.-EASL Congress; JUN 5-8, 2024; Milan, ITALY. [Poster]
Web of Science

 

Scheiner, B; Kang, B; Balcar, L; Radu, P; Reiter, FP; Adzic, G; Guo, J; Gao, X; Yuan, X; Cheng, L; Gorgulho, J; Schultheiss, M; Ben Khaled, N; Sinner, F; D'Alessio, A; Pomej, K; Saborowski, A; Schwacha-Eipper, B; Zarka, V; Lampichler, K; Nishida, N; Lee, PC; Krall, A; Saeed, A; Himmelsbach, V; Tesini, G; Wietharn, B; Huang, YH; Vivaldi, C; Masi, G; Vogel, A; Schulze, K; Trauner, M; Stauber, RE; Kudo, M; Dekervel, J; Parikh, N; Dufour, JF; Prejac, J; Geier, A; Bengsch, B; von Felden, J; Venerito, M; Philipp, A; Finkelmeier, F; Ji, FP; Wang, HW; Rimassa, L; Pinato, DJ; Bouattour, M; Chon, HJ; Pinter, M Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapy-based systemic therapy
J HEPATOL. 2024; 80: S69-S69.-EASL Congress; JUN 5-8, 2024; Milan, ITALY. [Oral Communication]
Web of Science

 

Balcar, L; Scheiner, B; Fulgenzi, CAM; D'Alessio, A; Pomej, K; Cheon, J; Nishida, N; Lee, PC; Wu, L; Ang, CSP; Krall, A; Saeed, A; Stefanini, B; Cammarota, A; Pressiani, T; Mohamed, YI; Chamseddine, S; Wietharn, B; Parisi, A; Huang, YH; Phen, S; Vivaldi, C; Salani, F; Masi, G; Bettinger, D; Vogel, A; Von Felden, J; Schulze, K; Silletta, M; Trauner, M; Samson, A; Wege, H; Piscaglia, F; Galle, PR; Stauber, RE; Kudo, M; Singal, AG; Ulahannan, S; Parikh, ND; Cortellini, A; Kaseb, A; Rimassa, L; Chon, HJ; Pinato, DJ; Pinter, M SEX-RELATED DIFFERENCES IN EFFICACY AND SAFETY OF IMMUNOTHERAPY IN HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS OF LANDMARK PHASE III TRIALS AND VALIDATION IN ROUTINE CLINICAL PRACTICE
HEPATOLOGY. 2023; 78: S1888-S1889.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Lax, S; Skok, K; Zechner, P; Aberle, S; Bargfrieder, U; Grosse, C; Salzer, H; Zlamal, T; Setaffy, L; Kessler, H; Dienes, HP; Trauner, M Hepatic alterations in COVID-19: a comparative autopsy study
J HEPATOL. Abstracts. 2023; 78(S1):S996-S997.-EASL Congress 2023; JUN 21-24, 2023; Vienna, AUSTRIA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, G; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar, D; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M COMPOSITE SCORES THAT INCLUDE LIVER STIFFNESS MEASUREMENT CAN PREDICT OUTCOMES IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S932-S935.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M LIVER STIFFNESS MEASUREMENT BASED COMPOSITE SCORES HAVE COMPARABLE PROGNOSTIC PERFORMANCE TO HISTOLOGICALLY ASSESSED FIBROSIS STAGE
HEPATOLOGY. 2023; 78: S995-S998.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Dr Shalimar; Hagström, SH; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M NASH SEVERITY ASSESSED BY THE NAFLD ACTIVITY SCORE (NAS) DOES NOT ADD PROGNOSTIC INFORMATION TO FIBROSIS STAGE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S1018-S1020.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M HISTOLOGICALLY ASSESSED FIBROSIS IS THE MAIN DETERMINANT OF PROGNOSIS IN PATIENTS IN NAFLD
HEPATOLOGY. 2023; 78: S971-S974.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Mozes, FE; Kaur, S; Vali, Y; Alzoubi, O; Wong, VWS; Li, GL; Wong, GLHC; Staufer, K; Trauner, M; Paternostro, R; Stauber, RE; Bugianesi, E; Gaia, S; Armandi, A; Lupsor-Platon, M; Sebastiani, G; Mahadeva, S; Rajaram, R; Zheng, MH; George, J; Eslam, MM; Pennisi, G; Aithal, GP; Palaniyappan, N; Lee, D; Nasr, P; Cassinotto, C; De Ledinghen, V; Berzigotti, A; Mendoza, YP; Noureddin, M; Truong, E; Boursier, J; De Saint Loup, M; Hirooka, M; Shima, T; Shalimar; Hagström, H; Ekstedt, M; Akbari, C; Chan, WK; Tsochatzis, EA; Liguori, A; Petta, S; Vigano, M; Ridolfo, S; Yoneda, M; Nakajima, A; Holleboom, AG; Van Dijk, AM; Mak, AL; Cobbold, JFL; Karlas, T; Wiegand, J; Fournier, C; Martic, M; Tuthill, T; Yunis, C; Anstee, QM; Harrison, S; Bossuyt, P; Pavlides, M CLASSIFICATION ACCORDING TO SEQUENTIALLY COMBINED NON-INVASIVE TESTS CARRIES PROGNOSTIC VALUE IN PATIENTS WITH NAFLD
HEPATOLOGY. 2023; 78: S928-S931.-Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 10-14, 2023; Boston, MA. [Poster]
Web of Science

 

Panzitt, K; Jungwirth, E; Madreiter-Sokolowski, C; Madl, T; Trauner, M; Fickert, P; Moore, DD; Thallinger, GG; Marschall, HU; Wagner, M; FXR signaling is shifted in humans with obesity and adapts hepatic mitochondrial function to increased substrate oxidation
Experimental Hepatology Days, Falk Symposium 233; MAY 18-20, 2023; Zurich, SWITZERLAND. 2023. [Oral Communication]

 

Pennisi, G; Enea, M; Falco, V; Aithal, GP; Palaniyappan, N; Yilmaz, Y; Boursier, J; Cassinotto, C; De Lédinghen, V; Chan, WK; Mahadeva, S; Eddowes, P; Newsome, P; Karlas, T; Wiegand, J; Wong, VWS; Schattenberg, JM; Labenz, C; Kim, W; Lee, MS; Lupsor-Platon, M; Cobbold, JFL; Fan, J; Shen, F; Staufer, K; Trauner, M; Stauber, R; Nakajima, A; Yoneda, M; Bugianesi, E; Younes, R; Gaia, S; Zheng, M; Cammà, C; Anstee, QM; Mózes, FE; Pavlides, M; Petta, S Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
DIGEST LIVER DIS. 2023; 55: S12-S13. Doi: 10.1016/j.dld.2023.01.022 [Oral Communication]
Web of Science FullText FullText_MUG

 

Scheiner, B; Sartoris, R; D'Alessio, A; Fulgenzi, C; Pomej, K; Balcar, L; Bouattour, M; Sidali, S; Himmelsbach, V; Finkelmeier, F; Schulze, K; von Felden, J; Hucke, F; Shmanko, K; Siebenhüner, A; Mertens, JC; De Dosso, S; Ebert, M; Teufel, A; Waldschmidt, DT; Radu, IP; Krall, A; Trauner, M; Dufour, JF; Wege, H; Weinmann, A; Trojan, J; Stauber, RE; Peck-Radosavljevic, M; Hsu, WF; Vogel, A; Ronot, M; Pinato, DJ; Pinter, M Validation of the CRAFITY score in patients with hepatocellular carcinoma treated with atezolizumab and bevacizumab
J HEPATOL. 2023; 78: S491-S492. [Poster]
Web of Science

 

Trauner, M; Fickert, P; Trivedi, P; Denk, G; Färkkilä, M; Dill, M; Villadsen, GE; Berg, C; Jorgensen, KK; Vetter, M; Müller, T; Müllhaupt, B; Schramm, C; Strassburg, C; Bantel, H; Böttler, T; Beuers, U; Louvet, A; Halilbasic, E; Stiess, M; Proels, M; Manns, MP Norucholic acid for the treatment of primary sclerosing cholangitis: baseline data from a phase III trial
J HEPATOL. Abstracts. 2023; 78(S1):S403-S403.-EASL Congress 2023; JUN 21-24, 2023; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Dixon, ED; Nardo, AD; Claudel, T; Fuchs, C; Mlitz, V; Stojakovic, T; Scharnagl, H; Grabner, G; Zimmermann, R; Trauner, M Chemical suppression of adipose triglyceride lipase improves non-alcoholic steatohepatitis in a diabetic and hyperlipidemic mouse model
J HEPATOL. 2022; 77: S688-S689. [Poster]
Web of Science

 

Fuchs, C; Dixon, ED; Konigshofer, P; Mlitz, V; Scharnagl, H; Stojakovic, T; Reiberger, T; Trauner, M Loss of bile salt export pump (BSEP/ABCB11) protects mice from development of carbon tetrachloride (CCl4) induced hepatic fibrosis
J HEPATOL. 2022; 77: S469-S469. [Poster]
Web of Science

 

Hartl, L; Tatscher, E; Weiß, M; Balcar, L; Strassl, R; Jachs, M; Mandorfer, M; Soliman, T; Stadlbauer, V; Schemmer, P; Berlakovich, G; Tilg, H; Schneeberger, S; Trauner, M; Fickert, P; Reiberger, T; Graziadei, I Impact of COVID-19 on liver transplantation in Austria.
Abstracts 55. Jahrestagung & 32. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). 2022; -55. Jahrestagung & 32. Fortbildungskurs der ÖGGH Hybridveranstaltung; SEPT 7-9, 2022; Vienna, AUSTRIA. [Poster]

 

Munda, P; Tulaeva, I; Stauber, RE; Gattringer, P; Trauner, M; Brunar, H; Valenta, R; Ferenci, P Induction of pre-s antobodies in HBeAg negative chronic hepatitis B patients by thereupatic vaccination with the pre-s based vaccine VVX001-interim analysis
J HEPATOL. 2022; 77: S854-S854.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

Staufer, K; Huber, H; Zessner-Spitzenberg, J; Stauber, RE; Finkenstedt, A; Bantel, H; Weiss, T; Huber, M; Starlinger, P; Grunberger, T; Reiberger, T; Sebens, S; McIntyre, G; Tabibiazar, R; Giaccia, A; Zoller, H; Trauner, M; Mikulits, W Large-scale multicenter study for the clinical utility of the non-invasive biomarkers Gas6 and soluble Axl in hepatocellular carcinoma, liver fibrosis and end-stage liver disease
J HEPATOL. 2022; 77: S470-S470.-EASL Annual Meeting; JUN 22-26, 2022; London, UK. [Poster]
Web of Science

 

Mozes, F; Lee, J; Selvaraj, E; Jayaswal, A; Trauner, M; Boursier, J; Fournier, C; Staufer, K; Stauber, R; Bugianesi, E; Younes, R; Gaia, S; Lupsor-Platon, M; Petta, S; Shima, T; Okanoue, T; Mahadeva, S; Chan, WK; Eddowes, P; Newsome, PN; Wong, VWS; de Ledinghen, V; Fan, JG; Shen, F; Cobbold, J; Sumida, Y; Okajima, A; Schattenberg, J; Labenz, C; Kim, W; Lee, MS; Wiegand, J; Karlas, T; Yilmaz, Y; Aithal, G; Palaniyappan, N; Cassinotto, C; Aggarwal, S; Harshit, G; Ooi, G; Nakajima, A; Yoneda, M; Ziol, M; Barget, N; Geier, A; Tunill, T; Brosnan, MJ; Anstee, Q; Neubauer, S; Harrison, S; Bossuyt, P; Pavlides, M Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis
J HEPATOL. ILC 2021 Abstracts. 2021; 75: S259-S260.-The International Liver Congress; JUN 23-26, 2021; Virtuell. [Poster]
Web of Science

 

Burbaum, B; Schneider, C; Hamesch, K; Fromme, M; Mandorfer, M; Reichert, M; Arslanow, A; Woditsch, V; Bals, R; Pereira, V; Carvao, J; Lammert, F; Trauner, M; Krag, A; Denk, H; Trautwein, C; Strnad, P European Study: Heterozygous Alpha-1-Antitrypsin Deficiency (Pi*MZ) genetic Risk Factor for Hepatopathy.
INTERNIST. Abstracts zum 126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. 2020; 61(SUPPL 1):S5-S6.-126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.; APR 25-28, 2020; Wiesbaden, GERMANY. [Poster]
Web of Science

 

Bruschi, F; Tardelli, M; Claudel, T; Zimmermann, R; Lotersztajn, S; Trauner, M Lack of monoacylglycerol lipase protects from MCD-induced hepatic inflammation and fibrosis
J HEPATOL. International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). 2019; 70(1):E58-E58.-International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 10-14, 2019; Vienna, AUSTRIA. Doi: 10.1016/S0618-8278(19)30104-5 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, C; Mlitz, V; Tardelli, M; Remetic, J; Menz, M; Paumgartner, G; Wolfrum, S; Wahlstrom, A; Stahlman, M; Stojakovic, T; Wolfrum, C; Marschall, HU; Trauner, M Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through anti-inflammatory bile acid composition and signaling
J HEPATOL. 2019; 70: E163-E164. Doi: 10.1016/S0618-8278(19)30291-9 [Poster]
Web of Science FullText FullText_MUG

 

Menz, M; Hinterleitner, L; Konigshofer, P; Halilbasic, E; Kunczer, V; Stojakovic, T; Reiberger, T; Fuchs, C; Trauner, M Glucagon like peptide-2 treatment improves liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis
J HEPATOL. 2019; 70: E167-E168. Doi: 10.1016/S0618-8278(19)30301-9 [Poster]
Web of Science FullText FullText_MUG

 

Remetic, J; Mlitz, V; Kunczer, V; Schargl, H; Stojakovic, T; Fuchs, C; Trauner, M Loss of bile salt export pump (Bsep/Abcb11) aggravates lipopolysaccharide induced hepatic inflammation in mice
J HEPATOL. 2019; 70: E169-E169. Doi: 10.1016/S0618-8278(19)30305-6 [Poster]
Web of Science FullText FullText_MUG

 

Tardelli, M; Bruschi, F; Claudel, T; Auer, N; Kunczer, V; Stojakovic, T; Herac, M; Lotersztajn, S; Trauner, M Monoacylglycerol lipase deletion protects against obesity-induced hepatic steatosis via PPARg regulation in adipose tissue and fatty acid malabsorption in the intestine
J HEPATOL. 2019; 70: E548-E548. Doi: 10.1016/S0618-8278(19)31087-4 [Poster]
Web of Science FullText FullText_MUG

 

Zhu, C; Boucheron, N; Muller, A; Majek, P; Fuchs, C; Baazim, H; Lercher, A; Halilbasic, E; Gulich, A; Sakaguchi, S; Sandner, L; Stojakovic, T; Scharnagl, H; Bergthaler, A; Ellmeier, W; Trauner, M 24-nor-ursodeoxycholic acid ameliorates inflammation by reshaping mTOR proteome and immunometabolism sensing programs in CD8 T cells
EUR J IMMUNOL. 2019; 49: 1282-1282.-17th International Congress of Immunology (IUIS); OCT 19-23, 2019; Beijing, PEOPLES R CHINA. [Poster]
Web of Science

 

Zhu, C; Boucheron, N; Muller, A; Majek, P; Fuchs, CD; Baazim, H; Halilbasic, E; Stojakovic, T; Bergthaler, A; Ellmeier, W; Trauner, M 24-nor-ursodeoxycholic acid ameliorates inflammation by reshaping mTOR proteome and immunometabolism sensing programs in CD8 T-cells
J HEPATOL. 2019; 70(1): E9-E10. Doi: 10.1016/S0618-8278(19)30016-7 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, C; Paumgartner, G; Mlitz, V; Wolfrum, S; Wahlstrom, A; Stahlman, M; Stojakovic, T; Wolfrum, C; Marschall, HU; Trauner, M Loss of BSEP protects MDR2/ABCB4 KO mice from cholestatic liver injury by altering bile acid profile and signaling
J HEPATOL. 2018; 68: S449-S450. Doi: 10.1016/S0168-8278(18)31141-3
Web of Science FullText FullText_MUG

 

Kozbial, K; Al-Zoairy, R; Schaefer, B; Gschwantler, M; Stauber, RE; Hametner, S; Maieron, A; Laferl, H; Strasser, M; Hayat-Khayyati, A; Datz, C; Kramer, L; Graziadei, I; Stattermayer, A; Beinhardt, S; Munda, P; Zoller, H; Trauner, M; Hofer, H; Ferenci, P Real world experience of retreatment of chronic hepatitis C patients who failed IFN-free DAA therapy
J HEPATOL. 2018; 68: S279-S280.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)30776-1 [Poster]
Web of Science FullText FullText_MUG

 

Pollheimer, M; Racedo, S; Mikels-Vigdal, A; Bowlus, C; Lackner, C; Karlsen, TH; Hov, JR; Lyman, SK; Adamkewicz, J; Smith, V; Moreau, E; Eide, TJ; Stojakovic, T; Stauber, RE; Trauner, M; Fickert, P Lysyl oxidase-like protein 2 in cholangiopathies
VIRCHOWS ARCH. 2018; 473: S6-S7.-30th European Congress of Pathology; 08-12.09, 2018 ; Bilbao. [Oral Communication]
Web of Science

 

Stauber, RE; Staufer, K; Stift, J; Marculescu, R; Obermayer-Pietsch, B; Trauner, M; Lackner, K Enhanced liver fibrosis (ELF) score accurately detects advanced fibrosis in nonalcoholic fatty liver disease (NAFLD)
J HEPATOL. 2018; 68: S563-S563.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE. Doi: 10.1016/S0168-8278(18)31383-7 [Poster]
Web of Science FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Kloters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl identifies patients at higher risk for hepatocellular carcinoma development: results from a large scale multicenter analysis
J HEPATOL. 2017; 66(1):S626-S626.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31697-5 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, CD; Paumgartner, G; Halilbasic, E; Leditznig, N; Wahlstrom, A; Stahlman, M; Stojakovic, T; Marschall, HU; Trauner, M Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating fecal bile acid composition and signaling
J HEPATOL. .. 2017; 66(1):S364-S364.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)31068-1 [Poster]
Web of Science FullText FullText_MUG

 

Moustafa, T; Zaufel, A; Eichmann, T; Kolb-Lenz, D; Trauner, M; Fickert, P Regulation of the mechanistic target of rapamycin complex 1 (mTORC1) - nuclear hormone receptor signaling by bile acids
J HEPATOL. 2017; 66(1):S111-S111.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30481-6 [Poster]
Web of Science FullText FullText_MUG

 

Panzitt, K; Marschall, HU; Trauner, M;Fickert, P; Wagner, M The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone. 2017; -Keystone bile acid meeting; March 5-9, 2017; Monterey, USA. [Poster]

 

Steinacher, D; Claudel, T; Griessner, J; Einwallner, E; Ruhlemann, MC; Ronda, O; Heinsen, FA; Stojakovic, T; Scharnagl, H; Verkade, HJ; Haubensak, WE; Trauner, M NorUDCA improves liver injury and metabolic situation in mouse models of obesity and steatosis
J HEPATOL. 2017; 66(1):S168-S168.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(17)30616-5 [Poster]
Web of Science FullText FullText_MUG

 

Beinhardt, S; Al-Zoairy, R; Freissmuth, C; Kozbial, K; Stern, R; Stattermayer, AF; Zoller, H; Maieron, A; Stauber, R; Staufer, K; Strasser, M; Vogel, W; Peck-Radosaljevic, M; Trauner, M; Ferenci, P; Hofer, H; SAFETY AND EFFICACY OF IFNANDRBV-FREE DAA-BASED REGIMENS IN HCV-RECURRENCE AFTER ORTHOTOPIC LIVER TRANSPLANTATION.
J HEPATOL. 2016; 64: S818-S818. Doi: 10.1016/S0168-8278(16)01599-3 [Poster]
Web of Science FullText FullText_MUG

 

Horvatits, T; Drolz, A; Roedl, K; Horvatits, K; Ferlitsch, A; Fauler, G; Trauner, M; Fuhrmann, V Bile acids as marker for acute decompensation and ACLF in patients with liver cirrhosis
MED KLIN-INTENSIVMED. 2016; 111(4):381-381. [Poster]
Web of Science

 

Lemberger, U; Fuchs, C; Karer, M; Stojakovic, T; Meier, S; Schofer, C; Egger, G; Wrba, F; Gerner, C; Taketo, M; Trauner, M; Oesterreicher, CH; HEPATOCYTE SPECIFIC EXPRESSION OF A DOMINANT STABLE FORM OF B-CATENIN RESULTS IN EARLY LETHALITY DUE TO DISTURBANCES IN LIPID AND GLUCOSE METABOLISM.
J HEPATOL. JOURNAL OF HEPATOLOGY64: S687-S687. AMSTERDAM: ELSEVIER SCIENCE BV; ( Presented at: EASL International Liver Congress, Barcelona, SPAIN, APR 13-17, 2016) Doi: 10.1016/S0168-8278(16)01309-X
Web of Science FullText FullText_MUG

 

Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner,M; The autophagy inhibitor Rubicon is a direct FXR target in human liver and is induced in human cholestasis
Proceedings of the XXIV International Bile Acid Meeting. 2016; -XXIV International Bile Acid Meeting: Bile Acids in Health and Disease; JUN 17-18, 2016; Düsseldorf, GERMANY. [Poster]

 

Panzitt,K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M; The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone Symposia Abstract Book "Autophagy: Molecular and physiological mechanisms". 2016; -Autophagy: Molecular and Physiological Mechanisms (V1); JUN 5-9, 2016; Whistler, British Columbia, CANADA. [Poster]

 

Trauner, M; Fickert, P; Hirschfield, G; Reiter, F; Altorjay, I; Marschall, U; Farkkila, M; Schramm, C; Spengler, U; Chapman, R; Bergquist, A; Schrumpf, E; Nevens, F; Halilbasic, E; Greinwald, R; Proels, M; Manns, MP; NORURSODEOXYCHOLIC ACID IMPROVES CHOLESTASIS IN PRIMARY SCLEROSING CHOLANGITIS: RESULTS OF A PHASE II DOSE FINDING STUDY.
J HEPATOL. 2016; 64: S208-S209.-EASL International Liver Congress; APR 13-17, 2016; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(16)00171-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Beinhardt, S; Al Zoairy, R; Freissmuth, C; Kozbial, K; Hametner, S; Stern, R; Stauber, RE; Maieron, A; Staufer, K; Strasser, MP; Zoller, HM; Graziadei, I; Vogel, W; Peck-Radosavljevic, M; Trauner, M; Ferenci, P; Hofer, H Efficacy and safety of IFN-free, DAA-based treatment-regimens in patients with HCV-recurrence after Liver Transplantation: Real-life experience from Austria
HEPATOLOGY. . 2015; 62: 746A-747A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Beinhardt, S; Freissmuth, C; Al-Zoairy, R; Kozbial, K; Hametner, S; Stern, R; Stauber, R; Maieron, A; Staufer, K; Strasser, M; Zoller, H; Graziadei, I; Vogel, W; Peck-Radosavljevic, M; Trauner, M; Ferenci, P; Hofer, H EFFICACY AND SAFETY OF IFN-FREE ANTIVIRAL THERAPY IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION: REAL-LIFE EXPERIENCE FROM AUSTRIA
J HEPATOL. 2015; 62: S282-S283.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)30192-6 [Poster]
Web of Science FullText FullText_MUG

 

Beinhardt, S; Kozbial, K; Schmidt, A; Freissmuth, C; Mandorfer, M; Strassl, R; al Zoairy, R; Stauber, R; Strasser, M; Sunder-Plassmann, G; Trauner, M; Peck-Radosavljevic, M; Vogel, W; Hofer, H; Ferenci, P REAL LIFE EXPERIENCE WITH INTERFERON/RIBAVIRIN-FREE ANTIVIRAL TREATMENT IN RENAL TRANSPLANT RECIPIENTS AND ENDSTAGE RENAL DISEASE-PATIENTS ON DIALYSIS INFECTED WITH HEPATITIS C VIRUS
J HEPATOL. 2015; 62: S667-S667.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31073-4 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M ROLE OF FXR CONTROLLED Chop IN MEDIATING BILE ACID EFFECTS IN NAFLD.
J HEPATOL. 2015; 62(S2):S689-S689.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. [Poster]
Web of Science

 

Fuchs, CD; Paumgartner, G; Wahlström, A; Chiba, P; Stojakovic, T; Claudel, T; Marschall, HU; Trauner, M ABSENCE OF BSEP/ABCB11 PROTECTS FROM CHOLESTATIC LIVER AND BILE DUCT INJURY IN A MOUSE MODEL OF SCLEROSING CHOLANGITIS.
J HEPATOL. 2015; 62(S2):S232-S232.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. [Oral Communication]

 

Fuchs, CD; Paumgartner, G; Wahlström, A; Stojakovic, T; Marschall, H; Trauner, M Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Z Gastroenterol. 2015; 53(5):512-512.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]

 

Kienbacher, C; Dolak, W; Traussnigg, S; Steindl-Munda, P; Oettl, K; Stadlbauer, V; Knapp, S; Vogelsang, H; Trauner, M METABOLIC DISTURBANCES AFTER FRUCTOSE OVERCONSUMPTION ARE NOT LINKED TO INTESTINAL PERMEABILITY IN HEALTHY YOUNG VOLUNTEERS
J HEPATOL. 2015; 62: S719-S719.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31193-4 [Poster]
Web of Science FullText FullText_MUG

 

Kienbacher, C; Traussnigg, S; Halilbasic, E; Fuchs, C; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Claudel, T; Trauner, M Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?
Z Gastroenterol. 2015; 53(5):501-501.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]

 

Lemberger, UJ; Fuchs, C; Karer, M; Schöfer, C; Stojakovic, T; Wrba, F; Taketo, MM; Trauner, M; Österreicher, CH HEPATOCYTE SPECIFIC EXPRESSION OF A DOMINANT STABLE FORM OF BETA-CATENIN RESULTS IN CHOLESTATIC LIVER DISEASE.
J HEPATOL. 2015; 62(S2):S781-S781.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31341-6 [Poster]
Web of Science FullText FullText_MUG

 

Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
HEPATOLOGY. . 2015; 62: 538A-538A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Staufer, K; Stauber, R; Theek, C; von Darl, M; Traussnigg, S; Kienbacher, C; Lackner, C; Steindl-Munda, P; Schulz-Knappe, P; Trauner, M MINIMALLY INVASIVE DIAGNOSIS OF NAFLD AND DISCRIMINATION BETWEEN NAFL AND NASH BY AUTOANTIBODY SIGNATURES
J HEPATOL. 2015; 62: S746-S746.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31258-7 [Poster]
Web of Science FullText FullText_MUG

 

Steinacher, C; Claudel, T; Stojakovic, T; Trauner, M NorUDCA improves liver injury and glucose sensitivity in a mouse model of obesity and steatosis.
Z Gastroenterol. 2015; 53(5):510-510.-48. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 18-20, 2015; Salzburg, AUSTRIA. [Poster]

 

Steinacher, D; Claudel, T; Stojakovic, T; Trauner, M NorUDCA-Therapy leads to reduced Inflammation in Fat Tissue and the Liver, and improves Glucose-Tolerance in Ob/Ob Mouse Model of Obesity and Fatty Liver.
WIEN KLIN WOCHENSCHR. 2015; 127(17-18):738-738.-16. Jahrestagung der Österreichischen Adipositas Gesellschaft (ÖAG); OCT 23-24, 2015; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Steinacher, D; Claudel, T; Stojakovic, T; Trauner, M NorUDCA reduces liver injury and improves glucose sensitivity in a mouse model of obesity and steatosis.
HEPATOLOGY. . 2015; 62: 689A-689A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Stiedl, P; McMahon, R; Blaas, L; Stanek, V; Svinka, J; Grabner, B; Zollner, G; Kressler, S; Claudel, T; Muller, M; Mikulits, W; Esterbauer, H; Eferl, R; Haybaeck, J; Trauner, M; Casanova, E THE ROLE OF GROWTH HORMONE RECEPTOR IN LIVER FIBROSIS AND CANCER
J HEPATOL. 2015; 62: S792-S792.-50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver; APR 22-26, 2015; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(15)31366-0 [Poster]
Web of Science FullText FullText_MUG

 

Zöhrer, E; Jahnel, J; Fauler, G; Scharnagl, H; Stojakovic, T; Trauner, M; Nobili, V NONALCOHOLIC FATTY LIVER DISEASE: SERUM BILE ACID LEVELS IN CHILDREN AND ADOLESCENTS AS MARKER FOR PROGRESSION?
J HEPATOL. 2015; 62(S2):S717-S717.-50th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 22-26, 2015; Vienna, AUSTRIA. [Poster]
Web of Science

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M Role of FXR controlled CHOP in mediating bile acid effects in NAFLD.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M FXR CONTROLLED CHOP AS NOVEL KEY PLAYER IN NAFLD PROGRESSION.
J HEPATOL. 2014; 60(S1):S148-S148.-49th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 9-13, 2014; London, UNITED KINGDOM. [Poster]

 

Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Scharnagl, H; Österreicher, C; Hoesel, B; Paumgartner, G; Marschall, HU; Trauner, M ABCB11 (BSEP) knockout mice are proteced from methionine choline deficient diet induced steatohepatitis.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Fuchs, CD; Paumgartner, G; Wahlstrom, A; Chiba, P; Stojakovic, T; Claudel, T; Marschall, HU; Trauner, M Absence of BSEP/ABCB11 protects from cholestatic liver injury in mice.
HEPATOLOGY. 2014; 60: 405A-406A.-65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 07-11, 2014; Boston, USA. [Poster]
Web of Science

 

Fuchs, CD; Paumgartner, G; Wahlström, A; Chiba, P; Stojakovic, T; Claudel, T; Marschall, HU; Trauner, M Absence of BSEP/ABCB11 protects from cholestatic liver injury in mice.
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Hofer, H; Zollner, G; Fickert, P; Graziadei, I; Trauner, M Clinical Course And Outcome Of Patients With Sclerosing Cholangitis In Critically Ill Patients (Sc-Cip): High Mortality Without Liver Transplantation
HEPATOLOGY. 2014; 60: 354A-354A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

Hörl, G; Froehlich, H; Ferstl, U; Ledinski, G; Binder, J; Cvirn, G; Stojakovic, T; Trauner, M; Koidl, C; Tafeit, E; Hallström, S; Amrein, K; Scharnagl, H; Jürgens, G Simvastatin lowers polyethylene glycol-non -precitable LDL-single-IgG-immune complexes.
21. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 9-10, 2014; St. Gilgen, AUSTRIA. 2014. [Oral Communication]

 

Kienbacher, C; Traussnigg, S; Halilbasic, E; C; Fuchs, CD; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Claudel, T; Trauner, M DISTURBED ENERGY METABOLISM AND LIPID PROFILE AFTER A 4 WEEK HIGH ORAL FRUCTOSE CHALLENGE: POSSIBLE ROLE OF BILE ACIDS.
J HEPATOL. 2014; 60(S1):S351-S351.-49th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 9-13, 2014; London, UNITED KINGDOM. [Poster]

 

Kienbacher, C; Traussnigg, S; Halilbasic, E; Fuchs, C; Dolak, W; Steindl-Munda, P; Stojakovic, T; Fauler, G; Gajdosik, M; Krebs, M; Claudel, T; Trattnig, S; Krssak, M; Trauner, M Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: Potential role of bile acids?
-. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Krones, E; Glaenzer, D; Durchschein, F; Kirsch, A; Eller, K; Trauner, M; Rosenkranz, AR; Fickert, P Urinary NGAL Levels Reflect the Therapeutic Effects of norUDCA in Mice with Cholemic Nephropathy
HEPATOLOGY. 2014; 60: 329A-329A.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

Krones, E; Glanzer, D; Durchschein, F; Kirsch, A; Eller, K; Trauner, M; Rosenkranz, A; Fickert, P Urinary NGAL Levels reflect the therapeutic Effects of norUDCA in the Mouse Model of cholemic Nephropathy
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):577-577.-65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 07-11, 2014; Boston, MA. [Poster]
Web of Science

 

Rutter, K; Horvatits, T; Drolz, A; Fauler, G; Heinz, G; Hulsmann, M; Trauner, M; Fuhrmann, V IMPACT OF TOTAL SERUM BILE ACIDS IN CRITICALLY ILL PATIENTS
INTENS CARE MED. 2014; 40: S286-S286.-27th Annual Congress of the European-Society-of-Intensive-Care-Medicine (ESICM); SEP 27-OCT 01, 2014; Barcelona, SPAIN. [Poster]
Web of Science

 

Bettermann, K; Kuldeep Mehta, A; Lederer, EM; Ernst, C; Kessler, SM; Kojima, K; Cheng, X; Hoshida, Y; Bardessy, NM; Fuchs, BC; Tanabe, KK; Müller, HH; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Smole, C; Stojakovic, T; Scheideler, M; Nilsson, KPR; Kolbe, T; Rülicke, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Grabe, N; Müller, KM; Themanns, M; Moriggl, R; Campbell, JS; Thorgeirsson, S; Pasparakis, M; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Denk, H; Lackner, C; Haybaeck, J Dysbalanced Keratins promote Steatohepatitis-associated Liver Carcinogenesis
Der Pathologe, FP 08. 2013; 34(Issue6):591-591.-Joined Annual Meeting of the Swiss and Austrian Society for Pathology; NOV 7-9, 2013; Baden, Switzerland. [Oral Communication]

 

Bettermann, K; Mehta, AK; Lederer, E; Ernst, C; Kessler, SM; Chen, X; Hoshida, Y; Bardeesy, N; Fuchs, BC; Tanabe, KK; Müller, H; Svendova, V; Schimek, MG; Mach, M; Speicher, MR; Mahajan, V; Stumptner, C; Thueringer, A; Stojakovic, T; Longerich, T; Schirmacher, P; Magin, TM; Strnad, P; Fuchs, CD; Trauner, M; Spilka, R; Kiemer, AK; Teufel, A; Maass, T; Moriggl, R; Campbell, JS; Thorgeirsson, SS; Stauffer, J; Karin, M; Llovet, JM; Zatloukal, K; Lackner, C; Haybäck, J Steatohepatitis-associated Hepatocellular Carcinoma: Evidence of a Keratinopathy.
HEPATOLOGY. 2013; 58(S1):543A-543A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA. [Poster]
Web of Science

 

Fuchs, CD; Claudel, T; Halilbasic, E; Jha, P; Spindelboeck, W; Stojakovic, T; Trauner, M FXR controlled CHOP as novel key player in NAFLD progression.
HEPATOLOGY. 2013; 58(S1):542A-542A.-64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 1-5, 2013; Washington, DC, USA. [Poster]
Web of Science

 

Fuchs, CD; Claudel, T; Halilbasic, E; Stojakovic, T; Trauner, M INTRAHEPATIC CHANGES IN BILE ACID COMPOSITION PROTECTS BSEP (ABCB11) KO MICE FROM HEPATIC INFLAMMATION IN METHIONINE CHOLINE DEFICIENT DIET INDUCED NASH.
J HEPATOL. 2013; 58(S1):S32-S32.-48th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 24-28, 2013; Amsterdam, THE NETHERLANDS. Doi: 10.1016/S0168-8278(13)60072-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

Krones, E; Eller, K; Rosenkranz, A; Deutschmann, A; Kinslechner, K; Durchschein, F; Pollheimer, MJ; Trauner, M; Fickert, P norUDCA als Therapie der cholämischen Nephropathie
Jahrestagung der osterreichischen Gesellschaften für Hypertensiologie und Nephrologie; SEP 19-21, 2013; Linz, AUSTRIA. 2013. [Oral Communication]

 

Krones, E; Pollheimer, MJ; Deutschmann, A; Kinslechner, K; Durchschein, F; Eller, K; Rosenkranz, A; Trauner, M; Fickert, P norUDCA AMELIORATES CHOLEMIC NEPHROPATHY IN LONG-TERM COMMON BILE DUCT LIGATED MICE
J HEPATOL. 2013; 58: S43-S43. Doi: 10.1016/S0168-8278(13)60100-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Krones, E; Pollheimer, MJ; Durchschein, F; Kinslechner, K; Deutschmann, A;Eller, K; Kirsch, A; Rosenkranz, A; Marschall, HU; Trauner, M; Fickert, P norUDCA - A novel therapeutic option for cholemic nephropathy?
ISC - International Student Congress; JUL 10-12, 2014; Graz, AUSTRIA. 2013. [Oral Communication]

 

Mandorfer, M; Reiberger, T; Payer, BA; Breitenecker, F; Aichelburg, MC; Obermayer-Pietsch, B; Rieger, A; Puoti, M; Zangerle, R; Trauner, M; Peck-Radosavljevic, M REVISTING PREDICTORS OF VIROLOGIC RESPONSE TO PEGIFN plus RBV THERAPY IN HIV/HCV COINFECTED PATIENTS: THE ROLE OF METABOLIC FACTORS AND ELEVATED GGT LEVELS
J HEPATOL. . 2013; 58: S352-S353.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60862-4 [Poster]
Web of Science FullText FullText_MUG

 

Mueller, M; Marschall, HU; Claudel, T; Wagner, M; Fickert, P; Lackner, C; Einarsson, C; Thorell, A; Trauner, M URSODEOXYCHOLIC ACID COUNTERACTS LIPOTOXICITY AND INDUCES UNFOLDED PROTEIN RESPONSE IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2013; 58: S517-S517.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)61279-9 [Poster]
Web of Science FullText FullText_MUG

 

Pollheimer, MJ; Bowlus, C; Lackner, C; Karlsen, TH; Hov, JR; Lyman, S; Adamkewicz, J; Mikels-Vigdal, A; Marshall, D; Smith, V; Trauner, M; Fickert, P LYSYL OXIDASE-LIKE 2 (LOXL2) PROTEIN IS INDUCED IN HUMAN CHOLESTATIC LIVER DISEASE AND IN ANIMAL MODELS OF CHOLANGIOPATHIES
J HEPATOL. 2013; 58: S281-S282. Doi: 10.1016/S0168-8278(13)60696-0 [Poster]
Web of Science FullText FullText_MUG

 

Rutter, K; Ferlitsch, A; Maieron, A; Stattermayer, AF; Graziadei, I; Dulic, M; Gschwantler, M; Stauber, R; Hofer, H; Peck-Radosavljevic, M; Vogel, W; Trauner, M; Ferenci, P SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
J HEPATOL. . 2013; 58: S30-S30.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. Doi: 10.1016/S0168-8278(13)60067-7 [Poster]
Web of Science FullText FullText_MUG

 

Teckman, J; Fickert, P; Trauner, M Autophagy is induced by the bile acid norUDCA, which may be a potential therapy for alpha-1-antitrypsin deficiency
HEPATOLOGY. .. 2013; 58: 257A-257A.-64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases; NOV 01-05, 2013; Washington, DC. [Poster]
Web of Science

 

Durchschein, F; Pollheimer, MJ; Krones, E; Zollner, G; Trauner, M; Fickert, P Genetic Loss of Muscarine-3 Receptor Decreases Biliary Bicarbonate Secretion and Aggravates Cholestatic Liver Injury in Mice
HEPATOLOGY. 2012; 56: 334A-334A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science

 

Fuchs, C; Claudel, T; Kumari, P; Stojakovic, T; Halilbasic, E; Spindelboeck, W; Gonzalez, F; Trauner, M FXR IS A KEY PLAYER IN NAFLD DEVELOPMENT BY CONTROLLING CHOP EXPRESSION.
J HEPATOL. 2012; 56(S2):S490-S490.-47th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)61248-3 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, CD; Claudel, T; Stojakovic, T; Haemmerle, G; Trauner, M Changes in hepatic bile acid composition protect BSEP (ABCB11) KO mice from hepatic inflammation in methionine choline deficient (MCD)-diet induced NASH.
HEPATOLOGY. 2012; 56: 873A-874A.-63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 09-13, 2012; Boston, USA. [Poster]
Web of Science

 

Halilbasic, E; Claudel, T; Bachhofner, N; Kapusta, C; Fickert, P; Trauner, M Norursodeoxycholic Acid Counteracts Hepatic Acute Phase Response via Modulation of NF kappa B Signaling
HEPATOLOGY. 2012; 56: 539A-540A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science

 

Krones, E; Pollheimer, MJ; Durchschein, F; Kinslechner, K; Deutschmann, A; Trauner, M; Fickert, P norUDCA protects common bile duct ligated mice from collecting duct tubular epithelial lesions
Doctoral Day 2012; DEC 7, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

 

Krones, E; Pollheimer, MJ; Durchschein, F; Trauner, M; Fickert, P The effects of bile acids on renal collecting duct epithelial cell death - are bile acids the culprits in cholemic nephropathy?
HEPATOLOGY. 2012; 56: 544A-545A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA. [Poster]
Web of Science

 

Krones, E; Pollheimer, MJ; Durchschein, F; Trauner, M; Fickert, P norUDCA protects CBDL mice from bile acid-induced collecting duct tubular epithelial lesions
Falk Symposium 184 XXII International Bile Acid Meeting Hepatic and Extrahepatic Targets of Bile Acid Signaling ; SEPT 14 - 15, 2012; Vienna, AUSTRIA. 2012. [Poster]
FullText

 

Marschall, HU; Mueller, M; Claudel, T; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, K; Thorell, A; Trauner, M High Levels of Ursodeoxycholic Acid Act as FXR Antagonist and Deplete Liver Cholesterol due to Increased Bile Acid Synthesis in Morbidly Obese Patients.
classic paper presentation, electronic posters on the EASL member restricted website. 2012; -International Liver Congress(TM) 2012 by EASL; April 18-22, 2012; Barcelona, Spain. [Poster]

 

Marschall, HU; Mueller, M; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, C; Thorell, A; Trauner, M HIGH LEVELS OF URSODEOXYCHOLIC ACID ACT AS FXR ANTAGONIST AND DEPLETE LIVER CHOLESTEROL DUE TO INCREASED BILE ACID SYNTHESIS IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2012; 56: S515-S515.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)61319-1 [Poster]
Web of Science FullText FullText_MUG

 

Marzioni, M; Saccomanno, S; Agostinelli, L; Rychlicki, C; Pierantonelli, I; Trauner, M; Fickert, P; Mueller, T; Shanmukhappa, SK; Trozzi, L; De Minicis, S; Candelaresi, C; Svegliati-Baroni, G; Benedetti, A PDX-1/Hes-1 interaction is a determinant of cholangiocyte proliferative response in Sclerosing Cholangitis
HEPATOLOGY. 2012; 56: 207A-207A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science

 

Marzioni, M; Saccomanno, S; Agostinelli, L; Rychlicki, C; Pierantonelli, I; Trauner, M; Fickert, P; Muller, T; Shanmukhappa, K; Alpini, G; Trozzi, L; De Minicis, S; Candelaresi, C; Baroni, GS; Benedetti, A PDX-1/HES-1 INTERACTIONS DETERMINE CHOLANGIOCYTE PROLIFERATIVE RESPONSE TO INJURY: THE SIGNIFICANCE FOR SCLEROSING CHOLANGITIS
J HEPATOL. 2012; 56: S16-S16.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)60050-6
Web of Science FullText FullText_MUG

 

Putz-Bankuti, C; Pilz, S; Meinitzer, A; Maerz, W; Kienreich, K; Stojakovic, T; Trauner, M; Pieber, TR; Stauber, RE ASSOCIATION OF HOMOARGININE AND METHYLARGININES WITH LIVER DYSFUNCTION AND MORTALITY IN CIRRHOTIC PATIENTS.
J HEPATOL. 2012; 56(S2):S255-S255.-47th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)60656-4 [Poster]
Web of Science FullText FullText_MUG

 

Putz-Bankuti, C; Pilz, S; Meinitzer, A; März, W; Kienreich, K; Stojakovic, T; Trauner, M; Pieber, TR; Stauber, RE Association of homoarginine and methylarginines with liver dysfunction and mortality in cirrhotic patients.
Z Gastroenterol. 2012; 50(5):517-517.-45. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); JUN 14-16, 2012; Wels, AUSTRIA. [Poster]

 

Salzl, P; Wagner, D; Koenig, V; Heinisch, BB; Payer, BA; Ferlitsch, M; Reiberger, T; Schwarzer, R; Trauner, M; Peck-Radosavljevic, M; Ferlitsch, A Vitamin D3 levels predict survival but not portal hypertension in patients with liver cirrhosis
HEPATOLOGY. 2012; 56: 925A-925A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science

 

Stiedl, P; Blaas, L; Stanek, V; Musteanu, M; Zollner, G; Esterbauer, H; Eferl, R; Trauner, M; Casanova, E ROLE OF GROWTH HORMONE RECEPTOR IN LIVER FIBROSIS
J HEPATOL. 2012; 56: S147-S147.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. Doi: 10.1016/S0168-8278(12)60376-6
Web of Science FullText FullText_MUG

 

Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Adorini, L; Gonzalez, F; Schoonjans, K; Fickert, P; Trauner, M FXR BUT NOT TGR5 ACTIVATION STIMULATES HCO3-RICH BILE SECRETION AND AMELIORATES LIVER DAMAGE IN MDR2-/- (ABCB4-/-) MOUSE MODEL OF CHRONIC LIVER INJURY
HEPATOLOGY. 2011; 54: 425A-425A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA. [Oral Communication]
Web of Science

 

Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Halsegger, S; Adorini, A; Strazzabosco, M; Fickert, P; Trauner, M Therapeutic Targeting of Nuclear and Membrane Bile Acid Receptors in a Mouse Model of Chronic Cholestasis
; JAN 14-16, 2011; Salzburg, Austria. 2011. [Oral Communication]

 

Fickert, P; Silbert, D; Moustafa, T; Halilbasic, E; Krones, E; Durchschein, F; Thueringer, A; Pollheimer, MJ; Zollner, G; Denk, H; Trauner, M DIFFERENTIAL EFFECTS OF NORUDCA AND UDCA IN OBSTRUCTIVE CHOLESTASIS IN MICE
HEPATOLOGY. 2011; 54: 775A-775A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA. [Poster]
Web of Science

 

Fickert, P; Thueringer, A; Moustafa, T; Silbert, D; Yang, M; Jaeschke, H; Stokman, G; Wells, R; Eller, K; Rosenkranz, AR; Eggertsen, G; Denk, H; Trauner, M TUBULOINTERSTITIAL KIDNEY FIBROSIS AND CHRONIC RENAL FAILURE IN LONG-TERM COMMON BILE-DUCT-LIGATED MICE AS A RESULT OF COLLECTING DUCT INJURY: THE ROLE OF OSTEOPONTIN, FXR, AND CYP8B1
HEPATOLOGY. 2011; 54: 1250A-1251A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA.
Web of Science

 

Fickert, P; Thueringer, A; Moustafa, T; Yang, M; Jaeschke, H; Wells, RG; Stokman, G; Denk, H; Trauner, M LONG-TERM COMMON BILE DUCT-LIGATION IN MICE INDUCES TUBULOINTERSTITIAL KIDNEY FIBROSIS AND CHRONIC RENAL FAILURE: ROLE OF BILE ACID NUCLEAR RECEPTOR FXR AND OSTEOPONTIN
J HEPATOL. 2011; 54: S244-S244.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60602-8
Web of Science FullText FullText_MUG

 

Fuchs, CD; Claudel, T; Kumari, P; Stojakovic, T; Haemmerle, G; Halilbasic, E; Gumhold, J; Silbert, D; Koefeler, H; Zechner, R; Trauner, M ATGL (PNPLA2) KNOCKOUT MICE ARE PROTECTED FROM HEPATIC ER-STRESS VIA OLEIC ACID ACCUMULATION.
J HEPATOL. 2011; 54: S41-S42.-46th Annual Meeting of the European Association for the Study of the Liver (EASL); MAR 30-APR 3, 2011; Berlin, GERMANY. Doi: 10.1016/S0168-8278(11)60095-0 [Poster]
Web of Science FullText FullText_MUG

 

Fuchs, CD; Claudel, T; Stojakovic, T; Silbert, D; Maurer, B; Trauner, M BSEP (ABCB11) KO MICE ARE PROTECTED FROM HEPATIC INFLAMMATION IN METHIONINE CHOLINE DEFICIENT DIET INDUCED NASH.
HEPATOLOGY. 2011; 54: 1169A-1169A.-62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); NOV 04-08, 2011; San Francisco, USA. [Poster]
Web of Science

 

Grunhage, F; Hochrath, K; Krawczyk, M; Obermayer-Pietsch, B; Trauner, M; Lammert, F ASSOCIATION OF COMMON SNPS OF GENES REGULATING VITAMIN D HOMEOSTASIS WITH VITAMIN D LEVELS AND LIVER FIBROSIS IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASE
ANTICANCER RES. 2011; 31(4):41-
Web of Science

 

Grunhage, F; Hochrath, K; Krawczyk, M; Obermayer-Pietsch, B; Trauner, M; Lammert, F ASSOCIATION OF GENES REGULATING VITAMIN D HOMEOSTASIS WITH VITAMIN D LEVELS AND LIVER FIBROSIS IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASE
J HEPATOL. 2011; 54: S48-S49.-46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); 2011; Berlin, GERMANY.
Web of Science

 

Grunhage, F; Hochrath, K; Krawczyk, M; Obermayer-Pietsch, B; Trauner, M; Lammert, F GENETIC CONTROL OF VITAMIN D LEVELS AND LIVER FIBROSIS BY VARIANTS IN GENES REGULATING VITAMIN D HOMOEOSTASIS IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASE
HEPATOLOGY. 2011; 54: 1217A-1218A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA.
Web of Science

 

Hochrath, K; Krawczyk, M; Obermayer-Pietsch, B; Trauner, M; Lammert, F; Grunhage, F SERUM 25-HYDROXY-VITAMIN D-3 IN CHRONIC LIVER DISEASE: A TRANSIENT ELASTOGRAPHY-BASED STUDY
ANTICANCER RES. 2011; 31(4):43-
Web of Science

 

Jahnel,J; Urban,C; Deutschmann,A; Lackner,H; Kroisel,P; Ebetsberger-Dachs,G; Trauner,M; Hauer,AC The bile salt export pump (Bsep) polymorphism V444a potentially causes jaundice as the presenting symptom of acute lymphoblastic leukemia (ALL)
Book of Abstracts of the 44th ESPGHAN-Meeting 2011; -44th Annual Meeting of the European Society for Paediatric Gastroenterology,Hepatology and Nutrition ( ESPGHAN) ; MAI 25-28,2011; Sorrento . [Oral Communication]

 

Kumari, P; Claudel, T; Kofeler, H; Schittmayer, M; Grunberger, RB; Baghdasaryan, A; Das, S; Zechner, R; Hofler, G; Trauner, M ADIPOSE TRIGLYCERIDE LIPASE (PNPLA2) IS A NOVEL KEY PLAYER IN PROTECTION FROM NASH
HEPATOLOGY. 2011; 54: 1154A-1154A.-62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 04-08, 2011; San Francisco, CA. [Poster]
Web of Science

 

Pollheimer, MJ; Fickert, P; Langner, C; Karlsen, TH; Trauner, M ADHESION MOLECULE EXPRESSION PATTERN IN PRIMARY SCLEROSING CHOLANGITIS AND DISEASE CONTROLS
J HEPATOL. 2011; 54: S516-S516. Doi: 10.1016/S0168-8278(11)61312-3 [Poster]
Web of Science FullText FullText_MUG

 

Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Halsegger, S; Adorini, L; Strazzabosco, M; Fickert, P; Trauner, M THERAPEUTIC TARGETING OF NUCLEAR AND MEMBRANE BILE ACID RECEPTORS IN A MOUSE MODEL OF CHRONIC CHOLESTASIS
HEPATOLOGY. 2010; 52(4):724--The 61st Annual Meeting of the Americal Association fro teh Study of liver Diseases; OCT 29-NOV 02, 2010; Boston, MA, USA. [Poster]
Web of Science

 

Baghdasaryan, A; Claudel, T; Gumhold, J; Silbert, D; Halsegger, S; Volkl, R; Adorini, L; Fickert, P; Trauner, M THERAPEUTIC EFFECTS OF FXR AND TGR5 ACTIVATION IN THE MDR2 (ABCB4)(-/-) MOUSE MODEL OF SCLEROSING CHOLANGITIS
J HEPATOL. 2010; 52: S354-S354.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)60914-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Beraza, N; Ofner-Ziegenfuss, L; Ehedego, H; Boekschoten, M; Mueller, M; Trauner, M; Trautwein, C NOR-UDCA ATTENUATES PROGRESSION OF NASH
J HEPATOL. 2010; 52: S304-S304. Doi: 10.1016/S0168-8278(10)60783-0 [Poster]
Web of Science FullText FullText_MUG

 

Fiorotto, R; Scirpo, R; Spirli, C; Trauner, M; Strazzabosco, M LACK OF CFTR AFFECTS THE INNATE IMMUNITY OF THE BILIARY EPITHELIUM AND DETERMINES A TLR4/NF-kappa B-MEDIATED INFLAMMATORY RESPONSE
J HEPATOL. 2010; 52: S20-S20. Doi: 10.1016/S0168-8278(10)60047-5 [Poster]
Web of Science FullText FullText_MUG

 

Fiorotto, R; Scirpo, R; Spirli, C; Trauner, MH; Strazzabosco, M ALTERED REGULATION OF TLR4 IN THE BILIARY EPITHELIUM OF CFTR-DEFECTIVE MICE DETERMINES AN INFLAMMATORY PHENOTYPE AND CAUSES LIVER DAMAGE AFTER INDUCTION OF DSS COLITIS
HEPATOLOGY. 2010; 52(4): 196
Web of Science

 

Fuchs, CD; Moustafa, T; Haemmerle, G; Halilbasic, E; Gumhold, J; Silbert, D; Fickert, P; Zechner, R; Trauner, M ADIPOSE TRIGLYCERIDE LIPASE (ATGL) IS A NOVEL MODULATOR OF HEPATIC ER-STRESS
J HEPATOL. 2010; 52: S305-S305.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)60787-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

Halilbasic, E; Claudel, T; Gumhold, J; Halsegger, S; Silbert, D; Fickert, P; Trauner, M PREGNANCY RESOLVES LIVER FIBROSIS AND IMPROVES SCLEROSING CHOLANGITIS IN MDR2 (ABCB4) -/- MICE VIA DIRECT ANTI-INFLAMMATORY EFFECTS OF SEX HORMONES
J HEPATOL. 2010; 52: S24-S24.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)60052-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Jahnel, J; Claudel, T; Baghdasaryan, A; Silbert, D; Gumhold, J; Fuchsbichler, A; Langner, C; Hauer, AC; Trauner, M Beeinflussung einer chemisch induzierten Colitis durch Änderungen des luminalen Phospholipidgehaltes im Maus-Modell
13. Interdisziplinäres Gastroenterologisch-Hepatologisches Wintertreffen; MAR 20-27, 2010; Galtür, AUSTRIA. 2010. [Oral Communication]

 

Kniepeiss, D; Wagner, D; Gütl, M; Krause, R; Aigelsreiter, A; Iberer, F; Müller, H; Fickert, P; Tscheliessnigg, KH; Trauner, M; Stiegler, P The liver takes it all.
Proceedings of the XXIII. Conference of the International Transplant Society2010; -XXIII. Conference of the International Transplant Society; Aug 15-19, 2010; Vancouver, Canada. [Poster]

 

Krones, E; Halilbasic, E; Grisold, A; Krause, R; Trauner, M; Fickert, P; Zollner, G Acute hepatitis species as a result of contamination of a food supplement with Cytotoxin-producing Bacillus species.
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A11. [Poster]
Web of Science

 

Kumari, P; Claudel, T; Kofeler, H; Schittmayer, M; Grunberger, RB; Zechner, R; Hofler, G; Trauner, M ADIPOSE TRIGLYCERIDE LIPASE (ATGL) IS A NOVEL KEY PLAYER IN PROTECTION FROM ACUTE HEPATIC INFLAMMATION
J HEPATOL. 2010; 52: S19-S19.-International Liver Congress™ 2010 – the 45th annual meeting of the European Association for the Study of the Liver (EASL) ; APR 14 -18, 2010; Doi: 10.1016/S0168-8278(10)60045-1 [Oral Communication]
Web of Science FullText FullText_MUG

 

Marschall, HU; Luketic, VA; Mason, AL; Lindor, KD; Hirschfield, GM; Gordon, SC; Mayo, MJ; Kowdley, KV; Pares, A; Trauner, M; Eliot, L; Hofmann, AF; Sciacca, CI; Shapiro, DA THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (INT-747, 6 alpha-ETHYL CHENODEOXYCHOLIC ACID) IN COMBINATION WITH URSODEOXYCHOLIC ACID (UDCA) INCREASES PLASMA FGF-19 CONCENTRATIONS BUT NOT BILE ACID CONCENTRATION OR PROFILE IN PRIMARY BILIARY CIRRHOSIS (PBC)
HEPATOLOGY. 2010; 52(4): 73
Web of Science

 

Mason, A; Luketic, V; Lindor, K; Hirschfield, G; Gordon, S; Mayo, M; Kowdley, K; Pares, A; Trauner, M; Castelloe, E; Sciacca, C; Jones, TB; Bohm, O; Shapiro, D FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF INT-747 TO URSODEOXYCHOLIC ACID
J HEPATOL. 2010; 52: S1-S2. Doi: 10.1016/S0168-8278(10)60004-9 [Poster]
Web of Science FullText FullText_MUG

 

Mason, AL; Luketic, VA; Lindor, KD; Hirschfield, GM; Gordon, SC; Mayo, MJ; Kowdley, KV; Pares, A; Trauner, M; Sciacca, CI; Jones, TB; Pruzanski, M; Shapiro, DA FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF OBETICHOLIC ACID (INT-747) TO URSODEOXYCHOLIC ACID
HEPATOLOGY. 2010; 52(4): 75
Web of Science

 

Moustafa, T; Fickert, P; Magnes, C; Frank, S; Kratky, D; Sinner, F; Gumhold, J; Silbert, D; Halsegger, S; Trauner M METABOLIC REPROGRAMMING OF LIPID METABOLISM BY THE SIDE-CHAIN MODIFIED BILE ACID, 24-NORURSODEOXYCHOLIC ACID, RESTORES INFLAMMATION-DRIVEN LIVER INJURY AND ABERRANT PROLIFERATION IN ABCB4-/- MICE
J HEPATOL. 2010; 52: S20-S21.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)60049-9 [Oral Communication]
Web of Science FullText FullText_MUG

 

Pooja Kumari 1*,2*, Claudia Fuchs 1*, Thierry Claudel 1, Harald Köfeler 3, Rudolph Zechner 4, Gerald Hoefler 2* and Michael Trauner 1* Role of ATGL in hepatic inflammation and lipotoxicity
3rd international Graz symposium on lipid and membrane biology. 2010; -3rd international Graz symposium on lipid and membrane biology; 18-20 March; Graz, Austria. [Oral Communication]

 

Pooja Kumari1,2, Thierry Claudel1, Astrid Knopf3, Harald Köfeler3, Matthias Schittmayer4, Ruth Birner-Grünberger4, Silvia Schauer2, Claudia Fuchs1, Anna Baghdasaryan1, Suman Das2, Tamilarasan2, Rudolf Zechner5, Gerald Höfler 2* and Michael Trauner1,6* Adipocyte triglyceride lipase is a novel key player in protection from NASH (Non-alcoholic steatohepatitis)
Joint ZMF and Doctoral day2010; -Joint ZMF and Doctoral day; Nov 4-6, 2010; Graz, Austria. [Poster]

 

Putz-Bankuti, C; Stojakovic, T; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, R Reduction of serum leptin levels during antiviral treatment with peginterferon and ribavirin in patients with chronic hepatitis C
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A10-A10.-41. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 29-OCT 2; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Rainer, PP; Huber, MS; Edelmann, F; Stojakovic, T; Trantina-Yates, A; Trauner, M; Pieske, BM; Von Lewinski, D The primary bile-salt glycocholate induces arrhythmias in human atrial myocardium
CARDIOVASC RES. 2010; 87: S50-S50. [Poster]
Web of Science

 

Rainer, PP; Huber, MS; Primessnig, U; Sedej, S; Halilbasic, E; Kockskämper, A; Edelmann, F; Fauler, G; Trauner, M; Pieske, B; von Lewinski, D Arrhythmogene Effekte von Gallensäuren am isolierten menschlichen Myokard
Clin Res Cardiology2010; -76. Jahrestagung der Deutschen Gesellschaft für Kardiologie; APR 8-10, 2010; Mannheim, GERMANY. [Poster]

 

Rainer, PP; Primessnig, U; Huber, MS; Sedej, SS; Halilbasic, E; Trauner, M; Yates, A; Pieske, B Pro-arrhythmic effects of increased primary bile-acid levels on human atrial myocardium
J f Kardiologie. 2010; -Annual Session of the Austrian Society for Cardiology; JUN 2-5; Salzburg, AUSTRIA. [Poster]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)61118-X [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum adipokine levels and lipoproteins in patients with chronic hepatitis C.
Clin Chem Lab Med 2010; 48(10):A211-A211.-3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum adipokine levels and lipoproteins in patients with chronic hepatitis C.
40. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2010; Maikammer, GERMANY. 2010. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE EFFECTS OF ANTIVIRAL TREATMENT ON SERUM LEPTIN LEVELS AND LIPID PROFILE IN PATIENTS WITH CHRONIC HEPATITIS C
ATHEROSCLER SUPPL. 2010; 11(2): MS456-78th Congress of the European Atherosclerosis Society; JUN 20-23, 2010; Hamburg, GERMANY. Doi: 10.1016/S1567-5688(10)70957-0
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Bauer, B; Pock, H; Trauner, M; Stauber, RE Effects of antiviral treatment on serum leptin levels and lipid profile in patients with chronic C.
17. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); MAY 7-8, 2010; St. Gilgen, AUSTRIA. 2010. [Oral Communication]

 

Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Tscheliessnigg, K; Pieber, T; Obermayer, B; Trauner, M; Fahrleitner, A Vitamin D Deficiency, Hyperparathyroidism and Bone Turnover in Patients Listed for Liver Transplantation (LTX).
AM J TRANSPLANT. 2010; 10: 350-350.-Annual Meeting of the American Society of Transplantation; MAY 2-8; San Diego, California. [Oral Communication]
Web of Science

 

Zollner, G; Thueringer, A; Lackner, C; Fickert, P; Trauner, M ALTERATIONS OF CANALICULAR ATP-BINDING CASSETTE TRANSPORTERS IN PATIENTS WITH DRUG-INDUCED LIVER INJURY
J HEPATOL. 2010; 52: S449-S449.-45th Annual Meeting of the European Association for the Study of the Liver; APR 14 - 18,2010; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(10)61163-4 [Poster]
Web of Science FullText FullText_MUG

 

Beraza, N; Ofner-Ziegenfuss, L; Ehedego, H; Boekschoten, MV; Muller, M; Trauner, M; Trautwein, C THERAPEUTIC EFFECT OF A NOR-UDCA BASED DIET ON NASH PROGRESSION IN THE CHRONIC DISEASE MODEL OF HEPATOCYTE-SPECIFIC NEMO DELETION
HEPATOLOGY. 2009; 50(4):1920- [Oral Communication]
Web of Science

 

Blaas, L; Kornfield, JW; Zollner, G; Schramek, D; Esterbauer, H; Trauner, M; Casanova, E ROLE OF STAT5 IN LIVER FIBROSIS
J HEPATOL. 2009; 50: 277- Doi: 10.1016/S0168-8278(09)60279-8 [Poster]
Web of Science FullText FullText_MUG

 

Farzi, A; Fickert, P; Moustafa, T; Silbert, D; Trauner, M mTOR signaling in chronic cholestatic liver injury.
Book of Abstracts and Conference Proceedings of the 1st annual meeting . 2009; -ÖGMBT (Austrian Association of Molecular Life Sciences and Biotechnology) Annual Meeting ; SEP 21-23, 2009; Innsbruck, AUSTRIA. [Poster]

 

Jahnel, J; Claudel, A; Baghdasaryan, A; Silbert, D, Gumhold, J; Fuchsbichler, A; Langner, C; Hauer, A Ch; Trauner, M Rolle von Phospholipiden in der Colitis Pathogenese: Einfluss reduzierter bilärer und nutritiver Phospholipide auf chemisch induzierte Colitis im Maus –Modell
Monatsschrift für Kinderheilkunde, Vol 157, Suppl2 (2009), S. 196.2009; 157(S2):196-196.-24. Jahrestagung der GPGE Hamburg, 01.-04.04.2009 ; APR 1-4, 2009; Hamburg, GERMANY. [Oral Communication]

 

Jahnel, J; Claudel, A; Baghdasaryan, A; Silbert, D; Gumhold, J; Fuchsbichler, A; Langner, C; Hauer, AC; Trauner, M Rolle von Phospholipiden in der Colitis Pathogenese: Einfluss reduzierter bilärer und nutritiver Phospholipide auf chemisch induzierte Colitis im Maus –Modell
47. Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde; OCT 1-3, 2009; Graz,AUSTRIA. 2009. [Oral Communication]

 

Jahnel, J; Claudel, T; Baghdasaryan, A; Langner, C; Fickert, P; Trauner, M; Hauer, AC; Silbert, A; Gumhold, J; Fuchsbichler, A PHOSPHOLIPIDS AND COLITIS: IMPACT OF NUTRITIONAL AND BILIARY LACK OF PHOSPHOLIPIDS IN A COLITIS MOUSE MODEL
ACTA PAEDIAT. 2009; 98: 29-30.-50th Annual Meeting of the European Society for Paediatric Research ; October 9-12, 2009 ; Hamburg, Germany. [Oral Communication]
Web of Science

 

Jahnel, J; Claudel, T; Baghdasaryan, A; Silbert, D; Gumhold, J; Fuchsbichler, A; Langner, C; Hauer, AC; Trauner, M Phospholipide und Colitis: Einfluss reduzierter biliärer und nutritiver Phospholipide auf chemisch induzierte Colitis im Maus-Modell
Abstractband zur 24. Jahrestagung der GPGE 2009; -24. Jahrestagung der GPGE ; APR 1-4, 2009; Hamburg, GERMANY. [Oral Communication]

 

Jahnel, J; Claudel, T; Baghdasaryan, A; Silbert, D; Gumhold, J; Fuchsbichler, A; Langner, C; Trauner, M Impact of Biliary and Nutritional Lack of Phospholipids in a Colitis Mouse Model
JCC2009; -4th Congress of ECCO - Inflammatory Bowel Diseases 2009. ; Feb 5-7, 2009; Hamburg, GERMANY. [Poster]

 

Jahnel, J; Claudel, T; Baghdasaryan, A; Silbert, D; Gumhold, J; Fuchsbichler, A; Langner, C; Trauner, M Impact of Biliary and Nutritional Lack of Phospholipids in a Colitis Mouse Model
Abstracts of Falk Symposium 1682009; -Falk Symposium 168; Mar 27-28, 2009; Madrid, SPAIN. [Poster]

 

Jahnel, J; Claudel, T; Raicht A; Fuchsbichler, A; Schwinger, W; Trauner, M IMMUNOPATHOGENESIS OF SCLEROSING CHOLANGITIS: LYMPHOCYTE SUBTYPES IN MDR2 (ABCB4) KNOCKOUT MICE.
abstracts2009; -EASL Monothematic Conference on Primary Sclerosing Chonlangitis; June 21-23, 2009; Oslo, Norway. [Poster]

 

Jahnel, J; Hauer, AC; Raicht, A; Fuchsbichler, A; Schwinger, W; Trauner, M Lymphocyte subpopulations in MDR2 (ABCB4) knockout mice as model for sclerosing cholangitis
Journal of Pediatric Gastroenterology and Nutrition (JPGN)2009; 48, Suppl. 3,: S. E61-S. E61.-42nd Annual Meeting of the European Society of Paediatric Gastroenterology and Nutrition (ESPGHAN); JUN 3-6, 2009; Budapest, Hungary. [Poster]

 

Jahnel, J; Raicht, A; Fuchsbichler, A; Schwinger, W; Trauner, M LYMPHOCYTE SUBTYPES IN MDR2 (ABCB4) KNOCKOUT MICE AS MODEL FOR SCLEROSING CHOLANGITIS
J HEPATOL. 2009; 50: 668- Doi: 10.1016/S0168-8278(09)60670-X [Poster]
Web of Science FullText FullText_MUG

 

Jahnel, J; Trauner, M Phospholipide und Colitis: Einfluss reduzierter biliärer und nutritiver Phospholipide auf chemisch induzierte Colitis im Maus-Modell
Abstractbuch 2009; -Deutsche Arbeitsgemeinschaft für chronisch-entzündliche Darmerkrankungen ; JUN 19-20, 2009; Mainz, Deutschland. [Oral Communication]

 

Jahnel, J; Trauner, M Colitis and Sclerosing Cholangitis: Intestinal Inflammation-associated Changes of Bile Secretion and Hepatobiliary Transporter Expression in Mice
Abstacts of UEGF2009; -UEGF Teaching Activity on Basic Science on “Cell Signalling and the Gut” in Cambridge 2009; Jul 19-21, 2009 ; Cambridge, Great Britain. [Oral Communication]

 

Jahnel, J;Claudel, T; Baghdasaryan, A;Silbert, D; Gumhold, J; Fuchsbichler, A; Langner, C; Trauner, M Impact of Biliary and Nutritional Lack of Phospholipids in a Colitis Mouse Model
JCC2009; -PIBD 2009 PIBD 2009; International Symposium on Pediatric Inflammatory Bowel Disease ; Sep 9-12, 2009; Paris, France. [Poster]

 

Klein, K; Eloranta, JJ; Wagner, M; Trauner, M; Kullak-Ublick, GA Regulation of human concentrative nucleoside transporter-1 gene expression
NAUNYN-SCHMIED ARCH PHARMACOL. 2009; 379: 490- [Oral Communication]
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Lundasen, T; Gustafsson, U; Sahlin, S; Trauner, M STIMULATION OF HEPATOBILIARY DETOXIFICATION AND TRANSPORT SYSTEMS IN HUMAN LIVER BY COMBINED TREATMENT WITH RIFAMPICIN AND URSODEOXYCHOLIC ACID
J HEPATOL. 2009; 50: 675-Vienna, Austria. Doi: 10.1016/S0168-8278(09)60677-2 [Poster]
Web of Science FullText FullText_MUG

 

Marshall, H; Wagner, M; Zoller, G; Fickert, P; Gustafsson, U; Sahlin, S; Trauner, M Combined treatment with rifamppicin and ursodeoxycholic acid in humans stimulates bile acid synthesis, detoxification and bilirubin elimination.
Gut2009; 58(SII):A49-A49.-GASTRO 2009 UEGW/WCOG; NOV 21-25,2009; London, GREAT BRITAIN. [Oral Communication]

 

Mattiassich, G; Genger, M; Robier, C; Baumann, K; Kapitan, M; Putz-Bankuti, C; Rainer, F; Trauner, M Die klinische Anwendung der Transient Elastographie mittels Fibroscan zur Evaluierung der Hepatotoxizität von Patienten mit chronischer Polyarthritis unter Langzeit-Methotrexattherapie.
Z Rheumatol2009; 68(Sup1):1-104.-EULAR Congress 2009; JUNE 10-13, 2009; Copenhagen, DENMARK. [Oral Communication]

 

Mattiassich, G; Robier, C; Genger, M; Parcz, D; Kapitan, M; Putz-Bankuti, C; Trauner, M; Rainer, F Die Anwendung nicht-invasiver serologischer Labortests (Fibrotest®) zur Erfassung der Leberfibrose bei Patienten mit chronischer Polyarthritis unter Langzeit-Methotrexattherapie.
Z Rheumatol2009; 68(Sup1):1-104.-EULAR Congress 2009; JUNE 10-13, 2009; Copenhagen, DENMARK. [Oral Communication]

 

Moustafa, T; Fickert, P; Magnes, CH; Halilbasic, E; Fuchsbichler, A; Sinner, F; Fauler, G; Vesely, P; Frank, S; Kratky, D; Gumhold, J; Silbert, D; Denk, H; Guelli, CH; Trauner, M 24-norursodeoxycholic acid, a side-chain modified bile acid targets inflammation, oxidative stress and lipid metabolism in chronic liver injury.
keine2009; -ZMF & Doctoral Day; Nov, 2009; Graz, AUSTRIA. [Poster]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Trauner, M Nuclear Receptors: Role in Pathophysiology and Treatment of Chronic Liver Disease.
42nd Annual Meeting of the Italian Association for the Study of the Liver; FEB 18-21, 2009; Rom, ITALY. 2009. [Keynote lecture]

 

Trauner, M Early Morning Workshop: Nuclear receptors.
American Association for the Study of the Liver Diseases; OCT 30 - NOV 3, 2009; Boston, USA. 2009. [Oral Communication]

 

Trauner, M Bile acids as regulators of hepatic lipid and glucose metabolism.
Falk Symposium: Liver and Metabolic Syndrome; OCT 15-16, 2009; Hamburg, GERMANY. 2009. [Oral Communication]

 

Trauner, M Drug therapy of chronic cholestatic syndromes and their complications.
GASTRO 2009 UEGW/WCOG; NOV 21–25, 2009; London, GREAT BRITAIN. 2009. [Oral Communication]

 

Trauner, M New insights into autoimmune cholangitis by animal models.
Falk Symposium: Immunology and Liver Disease; OCT 15-16, 2009; Hannover, GERMANY. 2009. [Oral Communication]

 

Trauner, M New pathophysiological mechanisms in cholestatic liver diseases. Role in therapy.
8th international meeting on therapy in liver diseases; SEP 23-25, 2009; Barcelona, SPAIN. 2009. [Oral Communication]

 

Trauner, M Specification and documentation of metabolic and neoplastic diseases.
Joint Biobank Symposium; JULY 8-9, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Trauner, M Role of bile acid-activated receptors and pathways in NAFLD.
10. Pichlschloss Transport Weekend; JUNE 25-28, 2009; Mariahof bei Neumarkt, AUSTRIA. 2009. [Oral Communication]

 

Trauner, M Role of bile acids in inflammation and carcinogenesis.
EASL Monothematic Conference: Primary Sclerosing Cholangitis; JUNE 21-23, 2009; Oslo. 2009. [Oral Communication]

 

Trauner, M Die Therapie der Primär Biliären Zirrhose.
Symposium Aktuelle Hepatologie; APR 18, 2009; Wiesbaden, GERMANY. 2009. [Keynote lecture]

 

Trauner, M Clinical trials with nuclear receptors ligands: Future proposals and needs.
Joint EASL – AASLD Monothematic Conference: Nuclear Receptors and Liver Disease; FEB 27 – MARCH 1, 2009; Vienna, AUSTRIA. 2009. [Oral Communication]

 

Trauner, M Association between angiogenesis and cholestasis.
ÖGGH Symposium: Liver Cirrhosis as a vascular disease; MAY 7 - 9, 2009; Vienna, AUSTRIA. 2009. [Oral Communication]

 

Trauner, M PSC: Pathomechanismen und therapeutische Konsequenzen.
6. HepNet Symposium; JUNE 5-6, 2009; Hannover, GERMANY. 2009. [Oral Communication]

 

Trauner, M Neue Therapieansätze für cholestatische Lebererkrankungen.
Universitätsklinik Innsbruck; JAN 21,2009; Innsbruck, AUSTRIA. 2009. [Oral Communication]

 

Trottier, J; El Husseini, D; Perreault, M; Paquet, S; Caron, P; Trauner, MH; Barbier, O HUMAN UDP-GLUCURONOSYLTRANSFERASE (UGT)1A3 CONJUGATES NORURSODEOXYCHOLIC ACID IN THE LIVER
HEPATOLOGY. 2009; 50(4):1551- [Oral Communication]
Web of Science

 

Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Pieber, TR; Obermayer-Pietsch, BM; Trauner, M; Fahrleitner-Pammer, A Vitamin D deficiency, hyperparathyroidism and bone turnover in patients listed for liver transplantation (LTX): Preliminary results of a cross-sectional study
BONE. 2009; 44(2):S400-S400.-ECTS; June 2009; Vienna; Austria. Doi: 10.1016/j.bone.2009.03.301 [Poster]
Web of Science FullText FullText_MUG

 

Wagner, D; Dobnig, H; Kniepeiss, D; Iberer, F; Pieber, TR; Obermayer-Pietsch, BM; Trauner, M; Fahrleitner-Pammer, A Vitamin D deficiency, hyperparathyroidism and bone turnover in patients listed for liver transplantation (LTX)
www.ectsoc.org. 2009; 44(2):400-400.-36th European Symposium on Calcified Tissue; may 23rd to 27 th; Vienna. [Poster]

 

Wehr, E; Giuliani, A; Trauner, M; Pieber, B; Obermayer-Pietsch, B Abnormal aminotransferase levels are associated with metabolic disturbances in polycystic ovary syndrome
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A20-A21.-Österreichische Gesellschaft für Innere Medizin; 17.-19.9.2009; Vienna, Austria. [Poster]
Web of Science

 

Baghdasaryan, A; Claudel, T; Kosters, A; Gumhold, J; Silbert, D; Fuchsbichler, A; Leski, K; Fickert, P; Karpen, SJ; Trauner, M Curcumin Feeding Ameliorates Cholangiopathy in Mdr2 (Abcb4) Knockout Mice
AASLD monothematic conference, ’’Pathobiology of Biliary Epithelia and Cholangiocarcinoma’’ . 2008; -AASLD monothematic conference, ’’Pathobiology of Biliary Epithelia and Cholangiocarcinoma’’ ; JUNE 6-8, 2008 ; Atlanta, GA, USA. [Poster]

 

Baghdasaryan, A; Kosters, A; Claudel, T; Fuchsbichler, A; Gumhold, J; Silbert, D; Leski, K; Fickert, P; Karpen, SJ; Trauner, M Curcumin improves liver injury and biliary fibrosis in MDR2 (ABCB4) knockout mice by inducing anti-oxidative response, but not via modification of bile acid transport/metabolism
J HEPATOL. 2008; 48: S171-S171.-EASL Annual Meeting; April 2008; Milan Italy. Doi: 10.1016/S0168-8278(08)60450-X [Poster]
Web of Science FullText FullText_MUG

 

Baghdasaryan, A; Kosters, A; Claudel, T; Fuchsbichler, A; Gumhold, J; Silbert, D; Leski, K; Fickert, P; Karpen, SJ; Trauner, M Curcumin improves liver injury in Mdr2 (Abcb4) knockout mice by inducing anti-oxidative response, but not via modification of bile acid transport/metabolism
XX International Bile Acid Meeting, ’’Bile Acid Biology and Therapeutic Actions’’ . 2008; -XX International Bile Acid Meeting, ’’Bile Acid Biology and Therapeutic Actions’’ ; JUNE 13-14, 2008; Amsterdam, the Netherlands. [Oral Communication]

 

Baghdasaryan, A; Kosters, A; Claudel, T; Fuchsbichler, A; Gumhold, J; Silbert, D; Leski, K; Fickert, P; Karpen, SJ; Trauner M. Curcumin improves liver injury in Mdr2 (Abcb4) knockout mice by inducing anti-oxidative response, but not via modification of bile acid transport/metabolism
XX International Bile Acid Meeting, ’’Bile Acid Biology and Therapeutic Actions’’. 2008; -XX International Bile Acid Meeting, ’’Bile Acid Biology and Therapeutic Actions’’.; June 13-14, 2008; Amsterdam, the Netherlands.. [Poster]

 

Fickert, P; Moustafa, T; Fuchsbichler, A; Claudel, T; Kratky, D; Denk, H; Trauner, M Differential effects of norUDCA and UDCA in the treatment of fatty liver disease and atherosclerosis.
keine2008; -ZMF Day; NOV, 2008; Graz, AUSTRIA. [Poster]

 

Fickert, P; Moustafa, T; Fuchsbichler, A; Claudel, T; Halilbasic, E; Zatloukal, K; Denk, H; Trauner, M Differential effects of nor UDCA and UDCA in the treatment of fatty liver and arteriosclerosis in western chow-fed ApoE knock out mice
J HEPATOL. 2008; 48: S42-S42.-Annual Meeting, EASL; April 2008; Milann, Italy. Doi: 10.1016/S0168-8278(08)60100-2 [Oral Communication]
Web of Science FullText FullText_MUG

 

Graham, D; Chen, M; Zhang, G; Swain, MG; Trauner, MH; Mason, AL THE NOD.C3C4 MOUSE MODEL OF PBC DEVELOPS BOTH MOUSE MAMMARY TUMOR VIRUS AND ABERRANT MITOCHONDRIAL ANTIGEN EXPRESSION IN BILE DUCTS
HEPATOLOGY. 2008; 48(4):653--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

 

Kratzer, A; Buchebner, M; Becker, TM; Pfeifer, T; Uray, G; Ebner, B; Rathke, N; Ahammer, H; Trauner, M; Hoefler, G; Levak-Frank, S; Levi, M; Kostner, GM; Kratky, D Partial LXR agonist reduces atherosclerosis in ApoE-deficient mice without inducing liver steatosis and hypertriglyceridemia
Experimental Biology 2008 (ASBMB); April 5-9, 2008; San Diego, USA. 2008. [Poster]

 

Kratzer, A; Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D Synthetic LXR agonist reduces atherosclerotic plaque formation in ApoE deficient mice without inducing liver steatosis and hypertriglyceridemia
OEGBM meeting 22th to 24th September 2008, Graz, Austria; SEPT 22-24, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Moustafa, T; Fickert, P; Fuchsbichler, A; Fauler, G; Streith, I; Vesely, P; Silbert, D; Gumhold, J; Denk, H; Trauner, M Side-chain modification of Ursodeoxycholic acid alters cellular hyper-proliferation and lipid homeostasis in a mouse model of chronic cholestatic liver injury.
keine2008; -ZMF Day; NOV, 2008; Graz, AUSTRIA. [Oral Communication]

 

Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Halilbasic, E; Trauner, MH LOSS OF FXR ATTENUATES SCLEROSING CHOLANGITIS AND BILIARY FIBROSIS IN MDR2(-/-) AND FXR(-/-) DOUBLE KNOCKOUT MICE
HEPATOLOGY. 2008; 48(4):777--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

 

Moustafa, T; Halilbasic, E; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Denk, H; Trauner, M Side chain modified bile acids modulate endoplasmic reticulum stress in Mdr2(-/-) mice in vivo and bile duct epithelial cells in vitro
J HEPATOL. 2008; 48: S54-S55.-EASL Annula Meeting; April 2008; Milan Italy. Doi: 10.1016/S0168-8278(08)60127-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

Pfeifer, T; Buchebner, M;Kratzer, A;Chandak, PG;Patankar, J;Obrowsky, S;Rechberger, GN;Halibasic, E;Trauner, M;Vistoli, G;Kostner, GM;Kratky, D;Levak-Frank, S; Synthetic LXR agonist reduces atherosclerotic plaque by lowering cholesterol absorption and inhibiting cholesterol biosynthesis
Cellular Lipid Transport - Connecting Fundamental Membrane Assembly; OCT 22-26, 2008 ; Canmore, CANADA. 2008. [Poster]
FullText

 

Sombetzki, M; Fickert, P; Loebermann, M; Holtfreter, M; Fuchsbichler, A; Gumhold, J; Silbert, D; Langner, C; Reisinger, EC; Trauner, M 24-nor-ursodeoxycholic acid as novel therapeutic strategy for inflammation-induced liver fibrosis in a murine model of schistosoma mansoni infection
J HEPATOL. 2008; 48: S21-S22.-Annual Meeting, EASL; April 2008; Mailand, Italien. Doi: 10.1016/S0168-8278(08)60052-5 [Oral Communication]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
Z Gastroenterol. 2008; 45: 1-1.-41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); MAI 29-31, 2008; Millstatt, AUSTRIA. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Wascher, TC; März, W; Trauner, M. Improvement of dyslipidemia and vascular function in patients with cholestatic liver disease after long-term treatment with atorvastatin
Hämostaseologie. 2008; 28(1-2):A62-A62.-52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 20-23, 2008; Wiesbaden, Germany. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Wagner, M; Scharnagl, H; Wascher, TC; Marz, W; Trauner, M Long-term treatment with atorvastatin in patients with cholestatic liver disease.
ATHEROSCLER SUPPL 2008; 9(1):197-197.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Seelhorst, U; Schilling, D; Winkelmann, BR; Boehm, BO; März, W Serum gamma-glutamyl transferase predicts cardiovascular mortality in persons undergoing coronary angiography – the Ludwigshafen Risk and Cardiovascular Health Study
3. Deutscher Atherosklerosekongress; SEP 19-20, 2008; Mannheim, GERMANY. 2008. [Poster]

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Seelhorst, U; Winkelmann, BR; Boehm, BO; Maerz, W Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography – the Ludwigshafen Risk and Cardiovascular Health Study.
European Heart Journal 2008; 29: 592-592.-ESC Congress 2008; AUG 30 - SEP 3, 2008; Munich, GERMANY. [Poster]

 

Sturm, E; Mulder, J; Stoeger, U; Havinga, R; Baller, JF; Gouw, AS; Kuipers, F; Trauner, MH IMPAIRMENT OF BILE FLOW IN LIVERS AFFECTED BY STEATOSIS OR STEATOHEPATITIS
HEPATOLOGY. 2008; 48(4):806--59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; OCT 31-NOV 04, 2008; San Francisco, CA. [Poster]
Web of Science

 

Trauner, M Cholestatische Lebererkrankungen.
41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; MAI 29-31, 2008; Millstatt, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Gallensäuren als therapeutische Targets für cholestatische und metabolische Lebererkrankungen.
Universität Tübingen, Medizinische Klinik IV; JUNE 19, 2008; Tübingen, GERMANY. 2008. [Keynote lecture]

 

Trauner, M Update Hepatologie: Fettleber, Cholestase, immunologische Lebererkrankungen.
LKH Judenburg-Knittelfeld, Abteilung für Innere Medizin; MAI 7, 2008; Judenburg, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Nichtalkolische Fettleber und Steatohepatitis.
Symposium der Gesellschaft für Innere Medizin an der Universität Graz; MÄRZ 12, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Animal Models of Cholangitis.
EASL Monothematic Conference: Immune Mediated Liver Injury; DEC 4-6, 2008; Hamburg, GERMANY. 2008. [Oral Communication]

 

Trauner, M MDR3 Deficiency.
59th Annual Meeting of the American Association for the Study of Liver Disease; OCT 31 - NOV 4, 2008; San Francisco, USA. 2008. [Oral Communication]

 

Trauner, M Differential effects of ursodeoxycholic acid (UDCA) and side-chain-shortened norUDCA in the treatment of fatty liver disease.
XX International Bile Acid Meetíng; JUNE 13-14, 2008; Amsterdam, NETHERLANDS. 2008. [Oral Communication]

 

Trauner, M Early Morning Workshop ‘Nuclear receptors in hepatology’.
43rd Annual Meeting of the European Association for the Study of the Liver; APR 23-27, 2008; Mailand, ITALY. 2008. [Oral Communication]

 

Trauner, M Advances in chronic cholestasis.
XXXIII Congreso Nacional Anual Asociacion Espanola para Estudio del Higado (Jahrestagung der Spanischen Lebergesellschaft); FEB 20-22, 2008; Madrid, SPAIN. 2008. [Keynote lecture]

 

Trauner, M Adipositas – Internistische Begleiterkrankungen (Diabetes mellitus, NASH, arterieller Hypertonus).
11. Interdisziplinäres Gastroenterologisch-hepatologisches Wintertreffen; MÄRZ 1-8, 2008; Obergurgl, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Cholestase und Ikterus - eine praxisorientierte Übersicht.
Kursus der klinischen Hepatologie; NOV 27-29, 2008; Hamburg, GERMANY. 2008. [Keynote lecture]

 

Trauner, M Molecular mechanisms of Cholestasis.
Karolinska University Hospital; APR 2, 2008; Stockholm, SWEDEN. 2008. [Keynote lecture]

 

Trauner, M Hepatits B – Alte Erkrankung – Neue Patienten.
39. Kongress für Allgemeinmedizin; NOV 20,2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Neue Herausforderungen in der Hepatitis B – Warum?
Symposium der Gesellschaft für Innere Medizin an der Universität Graz; OKT 2, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Hepatitis C und Adipositas.
41. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie; MAI 29-31, 2008; Millstatt, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Sklerosierende Cholangitis – neue Tiermodelle und ihre klinische Relevanz.
Univ.-Klinik f. Innere Medizin III, Medizinische Universität Wien; JAN 23, 2008; Vienna, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Primary biliary cirrhosis therapy advances.
XXXI Congreso Panamericano de Gastroeterologia; NOV 10-14, 2008; Santiago de Chile, CHILE. 2008. [Oral Communication]

 

Trauner, M Non-alcoholic fatty liver: advances in pathogenesis.
XXXI Congreso Panamericano de Gastroeterologia; NOV 10-14, 2008; Santiago de Chile, CHILE. 2008. [Oral Communication]

 

Trauner, M Differential diagnosis of liver disease.
XXXI Congreso Panamericano de Gastroeterologia; NOV 10-14, 2008; Santiago de Chile, CHILE. 2008. [Oral Communication]

 

Trauner, M Cholestasis and complications of cirrhosis.
Falk Workshop ‘Digestive Diseases: State of the Art and Daily Practice’; NOV 12, 2008; Santiago de Chile, CHILE. 2008. [Oral Communication]

 

Trauner, M Hepatitis.
Falk Workshop ‘Digestive Diseases: State of the Art and Daily Practice’; NOV 12, 2008; Santiago de Chile, CHILE. 2008. [Oral Communication]

 

Trauner, M Cholestatic liver diseases.
Falk Workshop ‘Digestive Diseases: State of the Art and Daily Practice’; NOV 12, 2008; Santiago de Chile, CHILE. 2008. [Keynote lecture]

 

Trauner, M Early Morning Workshop: Transport of Bile.
59th Annual Meeting of the American Association for the Study of Liver Disease; OCT 31 - NOV 4, 2008; San Francisco, USA. 2008. [Oral Communication]

 

Trauner, M Jack Edward Berk Memorial Lecture: Molecular pathogenesis of cholestasis.
25th Bockus Congress; OCT 14-17, 2008; Budapest, HUNGARY. 2008. [Keynote lecture]

 

Trauner, M Nuclear Receptors in the pathogenesis of cholestatic liver disease: targets for novel therapeutic strategies.
Prague Hepatology Meeting 2008; SEP 28-20, 2008; Prague, CZECH REPUBLIC. 2008. [Oral Communication]

 

Trauner, M Liver support for hepatogenic pruritus.
The 10th Anniversary “Past, Presence, and Future of Liver Support Therapy”; SEP 12-14, 2008; Rostock, GERMANY. 2008. [Oral Communication]

 

Trauner, M Cholestase in Mäusen und Menschen.
Symposium in honour of Prof. Dr. Helmut Denk; OKT 11, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Leberprobleme bei kritisch Kranken.
39. Österreichische Gesellschaft für Innere Medizin; SEP 17-20, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Trauner, M Erhöhte Leberwerte: Lifestyle-Modifikation und abwarten.
39. Österreichische Gesellschaft für Innere Medizin; SEP 17-20, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Cavic, T; Fruhwald, S; Holzer, P; Trauner, M; Metzler, H Effect of bile acids on guinea pig small bowel motility in vitro.
20th Congress of the European Society of Intensive Care Medicine; OCT 7-10, 2007; Berlin, GERMANY. 2007. [Poster]

 

Geier, A; Dietrich, CG; Trauner, M; Gartung, C Extrahepatic cholestasis down-regulates Oatp1 by TNF-alpha signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver
J HEPATOL. 2007; 46: S121-S121.-Annual Meeting, European Asociation for the Study of the Liver; April 11-15, 2007; Barcelona, Spain. Doi: 10.1016/S0168-8278(07)61904-7 [Poster]
Web of Science FullText FullText_MUG

 

Genger, M; Mattiassich, G; Trauner, M; Kapitan, M; Lunzer, R; Nadler, K; Rainer, F Long-term tolerance to low-dose methotrexate treatment in elderly patients with chronic polyarthritis. Retrospective analysis of 287 patients.
Z RHEUMATOL. 2007; 66: 89-89. [Oral Communication]
Web of Science

 

Halilbasic, E; Fickert, P; Fuchbichler, A; Langner, C; Gumhold, J; Silbert, D; Maitra, U; Zatloukal, K; Denk, H; Trauner, M Taurine-conjugation critically determines the therapeutic effectiveness of 24-nor-ursodeoxycholic acid (norUDCA) in the treatment of sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
J HEPATOL. 2007; 46: S51-S51.-EASL; April 11-15, 2007; Doi: 10.1016/S0168-8278(07)61714-0 [Oral Communication]
Web of Science FullText FullText_MUG

 

Halilbasic, E; Fickert, P; Fuchsbichler, A; Moustafa, T; Stoeger, U; Ueno, Y; Denk, H; Trauner, M TNF alpha and LPS but not bile acids play a key role in the induction of reactive phenotype in bile duct epithelial cells in vitro
J HEPATOL. 2007; 46: S121-S121.-EASL; April 11-15, 2007; Barcelona/Spain. Doi: 10.1016/S0168-8278(07)61905-9 [Poster]
Web of Science FullText FullText_MUG

 

Jahnel, J; Wagner, M; Langner, C; Hoegenauer, C; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M Impact of colitis on bile secretion and hepatobiliary transporter expression in mice possible implications for pathogenesis of sclerosing cholangitis
J HEPATOL. 2007; 46: S122-S122. Doi: 10.1016/S0168-8278(07)61907-2 [Poster]
Web of Science FullText FullText_MUG

 

Maitz, S; Wimmer, R; Rust, C; Denk, H; Invernizzi, P; Ferdinandusse, S; Wanders, RJ; Fuchsbichler, A; Fickert, P; Trauner, M; Hofmann, AF; Beuers, U Taurine conjugation is essential for anticholestatic action of norursodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver
HEPATOLOGY. 2007; 46(4):338A-339A.-AASLD; NOV 2-6, 2007; Boston, USA. [Poster]
Web of Science

 

Mattiassich, G; Trauner, M; Kapitan, M; Genger, M; Nadler, K; Lunzer, R; Rainer, F The hepatotoxicity of low-dose long-term methotrexate therapy in the treatment of chronic polyarthritis. A retrospective analysis of the liver function parameter in 409 patients.
Z RHEUMATOL. 2007; 66: 85-86. [Oral Communication]
Web of Science

 

Moustafa, T; Fickert, P; Vesely, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Guelly, C; Trauner, M Retention of toxic bile acids activate the mTOR, p70S6k/rps6 signaling pathway in mouse models of cholestatic liver injury
J HEPATOL. 2007; 46: S23-S23. Doi: 10.1016/S0168-8278(07)61646-8 [Oral Communication]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Scharnagl, H; Trauner, M; Wellnitz, B; Ursula Seelhorst, U; Winkelmann, BR; Boehm, BO; März W Serum gamma-glutamyltransferase, cardiovascular disease and mortality risk – the Ludwigshafen Risk and Cardiovascular Health Study.
37. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 29 - DEC 1, 2007; Maikammer, Deutschland. 2007. [Oral Communication]

 

Wagner, M; Moustafa, T; Fickert, P; Zollner, G; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Absence of FXR protects mice from bile-infarcts in biliary obstruction by reduction of bile acid-independent bile flow: Implications for targeting FXR in treatment of cholestasis?
J HEPATOL. 2007; 46: S5-S5.-42th Annual Meeting, European Association for the Study of the Liver; April, 11-15, 2007; Barcelona, Spain. Doi: 10.1016/S0168-8278(07)61603-1 [Oral Communication]
Web of Science FullText FullText_MUG

 

Zatloukal K, Gottweis H, Eder J, Trauner M, Denk H, Samonigg H, Stöger U GATiB, Genome Austria Tissue Bank
GEN-AU Evaluierungskonferenz; APRIL, 16-17, 2007; Vienna, AUSTRIA. 2007. [Oral Communication]

 

Zollner, G; Caligiuri, A; Fickert, P; Wagner, M; Silbert, D; Pinzani, M; Trauner, M Expression of bile acid transport and detoxification systems and their regulatory nuclear receptors in human hepatic stellate cells
J HEPATOL. 2007; 46: S135-S135.-42th Annual Meeting, European Association for the Study of the Liver ; April 11-15, 2007; Barcelona, Spain. Doi: 10.1016/S0168-8278(07)61944-8 [Poster]
Web of Science FullText FullText_MUG

 

Bernhardt, GA; Zollner, G; Cerwenka, H; Bacher, H; Kornprat, P; Zatloukal, K; Trauner, M; Mischinger, HJ Influence of Pringle maneuver in liver resections on hepatobiliary transporter expression in hepatocytes and postoperative jaundice.
European Surgery. Eur Surg 2006; 38(S209):107--Congress of the Austrian Society of Surgery; JUN 6, 2006; Vienna. [Poster]

 

Bernhardt, GA; Zollner, G; Kornprat, P; Cerwenka, H; Bacher, H; Mischinger, HJ; Fickert, P; Trauner, M Influence of Pringle maneuver in liver resections on hepatobiliary transporter expression.
Hepato-Gastroenterology. Hepato-Gastroenterol 2006; 53(S1):178-179.-World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists; MAY 26, 2006; Madrid. [Poster]

 

Fauler, G; Stojakovic, T; Putz-Bankuti, C; Gurakuqi, GC; Scharnagl, H; Marz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
ATHEROSCLER SUPPL. 2006; 7(3):583-583.-XIV. International Symposium on Atherosclerosis; JUNE 18-22, 2006; Rome, Italy. Doi: 10.1016/S1567-5688(06)82367-6 [Poster]
Web of Science FullText FullText_MUG

 

Graziadei, IW; Nilica, B; Stadlbauer, V; Stauber, R; Trauner, M; Mueller, C; Vogel, W Imatinib treatment for patients with advanced stage hepatocellular carcinoma: A multicenter phase II trial
HEPATOLOGY. 2006; 44(4):503A-504A. [Poster]
Web of Science

 

Moustafa, T; Fickert, P; Fuchsbichler, A; Vesely, P; Silbert, D; Gumhold, J; Denk, H; Guelly, CH; Trauner, M he side-chain shortened bile acid 24-norUDCA reverses biliary fibrosis and alters cellular hyperproliferation in a mouse model of chronic cholestatic liver injury.
keine2006; -ZMF Day; NOV, 2006; Graz, AUSTRIA. [Oral Communication]

 

Moustafa, T; Fickert, P; Guelly, C; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M Transcriptional profiling of Mdr2 knockout (Mdr2-/-) mice treated with nor-UDCA reveals global anti-inflammatory and anti-fibrotic effects
J HEPATOL. 2006; 44: S42-S42.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80095-4 [Poster]
Web of Science FullText FullText_MUG

 

Moustafa, T; Fickert, P; Guelly, C; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M 24-nor-ursodeoxycholic acid abolishes enhanced cellular proliferation in Mdr2 (abcb4) knockout mice by modulation of mTOR, p70s6k and rps6 signaling
HEPATOLOGY. 44(4):602A-603A. [Poster]
Web of Science

 

Moustafa, T; Fickert, P; Kratky, D; Prokesch, A; Trajanoski, Z; Trauner, M The nuclear bile acid receptor FXR is required to balance intra-hepatic lipid synthesis, storage and utilization in a mouse model of cholestatic liver injury.
keine2006; -Keystone Symposium; JAN, 2006; Colorado, USA. [Poster]

 

Moustafa, T; Fickert, P; Prokesch, A; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Denk, H; Trajanoski, Z; Trauner, M Common bile-duct-ligation of FXR knockout mice results in severe hepatic steatosis due to enhancement in lipogenic gene expression
J HEPATOL. 44: S28-S28.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80063-2 [Poster]
Web of Science FullText FullText_MUG

 

Schwetz, I; Zollner, G; Trauner, M; Olschewski, H; Krause, R Clinical presentation of Leptospirosis in Graz, Austria
Interscience Conference on Antimicrobial Agents and Chemotherapy; Sept 27 -30, 2006; San Francisco. 2006. [Poster]

 

Stoger, U; Fickert, P; Fuchsbichler, A; Moustafa, T; Gumhold, J; Silbert, D; Zatlouka, K; Denk, H; Trauner, M 3.5-diethoxycarbonyl-1.4-dihydrocollidine (DDC) feeding induces cholestasis, chronic inflammatory bile duct damage and biliary fibrosis in mice
J HEPATOL. 44: S123-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80321-1 [Poster]
Web of Science FullText FullText_MUG

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Gurakuqi, G; Scharnagl, H; Stadlbauer, V; Stauber, R; Maerz, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and incomplete response to ursodeoxycholic acid.
Clin Chem Lab Med. 44(9):A207-A207.-First Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC); OCT 4-7, 2006; Salzburg, Austria. [Poster]

 

Voigt, S; Martin, IV; Trauner, M; Dietrich, CG; Gartung, C; Trautwein, C; Geier, A Maintained expression of alternative bile salt excretion pathways in inflammatory cholestasis in mice by treatment with class II nuclear hormon receptor ligands
HEPATOLOGY. 44(4):604A-605A. [Poster]
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Trauner, M 24-nor-ursodeoxycholic acid ameliorates sclerosing cholangitis in Mdr2 knockout mice.
4th Central European Gastroenterology Meeting; Juni 29 - Juli 2; Visegrad, Ungarn. 2006. [Oral Communication]

 

Wagner, M; Halilbasic, E; Marschall, HU; Zollner, G; Fickert, P; Langner, C; Zatloukal, K; Denk, H; Trauner, M CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8; Graz. 2006. [Oral Communication]

 

Zollner, G; Fuchsbichler, A; Fickert, P; Denk, H; Trauner, M Alterations of hepatic bilirubin and phospholipid export pumps MRP2 and MDR3 in patients with drug-induced liver injury
HEPATOLOGY. 44(4):381A-381A. [Poster]
Web of Science

 

Zollner, G; Wagner, M; Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Helmut, D; Marschall, HU; Trauner, M Role of nuclear bile acid receptor FXR in regulation of bile acid detoxification and organic solute transporter (OST-alpha/beta) expression in bile acid-fed mice
J HEPATOL. 44: S124-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. Doi: 10.1016/S0168-8278(06)80322-3 [Poster]
Web of Science FullText FullText_MUG

 

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Krause, R; Zatloukal, K; Marschall, HU; Jaeschke, H; Denk, H; Trauner, M Lithocholic acid feeding induces biliary obstruction and destructive cholangitis in mice
J HEPATOL. 2005; 42: 113-113.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Fickert, P; Wagner, M; Marshall, HU; Fuchsbichler, A; Zollner, G; Zatloukal, K; Liu, J; Waalkes, MP; Cover, C; Denk, H; Hofmann, AF; Jaeschke, H; Trauner, M 24-norursodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
HEPATOLOGY. 2005; 42: -56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science

 

Geier, A; Zollner, G; Dietrich, CG; Wagner, M; Fickert, P; Denk, H; van Rooijen, N; Matern, S; Gartung, C; Trauner, M Cytokine-independent repression of rodent Ntcp in obstructive cholestasis
J HEPATOL. 2005; 42: 114-114.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Janig, E; Fuchsbichler, A; Fickert, P; Trauner, M; Denk, H; Zatloukal, K Clusterin: A novel stress marker in biliary disease models
HEPATOLOGY. 2005; 42 (4): 413-414.-56th Annual Meeting of the American Association for the Study of Liver Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science

 

Jung, A; Krisper, P; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D Two-compartment model for kinetics of conjugated bilirubin during extracorporeal liver support therapy
NEPHROL DIALYSIS TRANSPLANT. 2005; 20: -42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA); JUN 04-07, 2005; Istanbul, TURKEY.
Web of Science

 

Krisper, P; Stadlbauer, V; Haditsch, B; Holzer, H; Trauner, M; Stauber, RE; Schneditz, D The bilirubin/albumin ratio does not influence the clearance of conjugated bilirubin in extracorporeal liver support (ELS)
NEPHROL DIALYSIS TRANSPLANT. 2005; 20: V117-V117.-42nd Annual Meeting of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA); JUN 04-07, 2005; Istanbul, TURKEY.
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Gustafsson, U; Sahlin, S; Einarsson, C; Trauner, M Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in human liver
GASTROENTEROLOGY. 2005; 128: A755-A755.
Web of Science

 

Marschall, HU; Wagnr, M; Bodin, K; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Sjovall, J; Trauner, M Fxr -/- mice adapt to obstructive cholestasis by enhanced phase I detoxification and renal elimination of bile acids
J HEPATOL. 2005; 42: 114-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Soroka, C; Zollner, G; Mennone, A; Ballatori, N; Trauner, M; Boyer, JL The heteromeric organic solute transporter, Ost alpha-Ost beta, is up-regulated in the liver of patients with primary biliary cirrhosis (PBC) and variably induced in rat and mouse cholangiocytes following bile duct ligation (BDL).
HEPATOLOGY. 2005; 42: -56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005. [Oral Communication]

 

Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, J; Zatloukal, K; Jaeschke, H; Deck, H; Trauner, M Role of inflammation for hepatobiliary transporter expression in ICAM-/- and lpr mice after common bile duct ligation
GASTROENTEROLOGY. 2005; 128: A89-A89.
Web of Science

 

Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, JS; Zatloukal, K; Denk, H; Jaeschke, H; Trauner, M Alterations of hepatobiliary transporter expression in response to common bile duct ligation in mice are independent of ICAM-1 and FAS-receptor expression
J HEPATOL. 2005; 42: 115-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis
GASTROENTEROLOGY. 2005; 128: A691-A691.
Web of Science

 

Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M Expression of key bile acid detoxification enzymes and the alternative bile acid export pump MRP4 in primary biliary cirrhosis
J HEPATOL. 2005; 42: 240-240.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Biliary leakage of fluorescent bile acids in MDR2 knockout mice: Evidence for a critical role of bile duct leakage in the pathogenesis of sclerosing cholangitis
J HEPATOL. 2004; 40: 91-91.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90295-4
Web of Science FullText FullText_MUG

 

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Bile acids regurgitation from leaky bile ducts causes sclerosing cholangitis in Mdr2 knockout mice
GASTROENTEROLOGY. 2004; 126: A663-A663.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Marschall, HU; Zartloukal, K; Denk, H; Zsengeller, Z; Szabo, C Oncosis represents the main type of cell death in mouse models of cholestasis: evidence for a critical role of poly(ADP-ribose) polymerase (PARP) activation in bile acid-induced hepatocytes death
FASEB J. 2004; 18: A558-A558.-Experimental Biology 2004 Meeting; APR 17-21, 2004; Washington, DC.
Web of Science

 

Hofer, H; Szalay, F; Lakatos, P; Oesterreicher, C; Willheim-Polli, C; Pirker, A; Trauner, M; Datz, C; Gschwantler, M; Habior, A; Penner, E; Ferenci, P NOD2/CARD15 mutations in patients with primary biliary cirrhosis.
HEPATOLOGY. 2004; 40: 465A-465A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

 

Knight, T; Fickert, P; Fuchsbichler, A; Trauner, M; Jaeschke, H Pathophysiological role of poly(adenosine 5'-diphosphate-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
HEPATOLOGY. 2004; 40: 650A-650A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

 

Krisper, P; Stauber, R; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D MARS versus Prometheus: Comparison of clearances as a measure of efficiency in two different liver detoxification devices
GASTROENTEROLOGY. 2004; 126: A706 -A706 .
Web of Science

 

Krisper, P; Stauber, R; Haditsch, B; Trauner, M; Holzer, H; Schneditz, D Mars versus prometheus: Comparison of reduction ratios (RR) as a measure of treatment dose in two different liver detoxification devices
J HEPATOL. 2004; 40: 69-70.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90216-4
Web of Science FullText FullText_MUG

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
GASTROENTEROLOGY. 2004; 126: A746-A746.
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumholdt, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
J HEPATOL. 2004; 40: 93-93.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90303-0
Web of Science FullText FullText_MUG

 

Popov, Y; Patsenker, E; Trauner, M; Schuppan, D MDR-2 KO mice develop rapid biliary fibrosis via massive up-regultion of procollagen I and TIMP-1 expression.
HEPATOLOGY. 2004; 40: 463A-463A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

 

Rudolph, CM; Trauner, M; Kerl, H; Mullegger, RR Pruritic skin conditions during pregnancy: Serum bile acid levels are a highly reliable parameter to diagnose intrahepatic cholestasis of pregnancy (ICP)
J INVEST DERMATOL. 2004; 123:
Web of Science

 

Rudolph, CM; Trauner, M; Kerl, H; Müllegger, RR Juckreiz in der Schwangerschaft: erhöhte Serumgallensäurewerte sind diagnostisch für die intrahepatische Schwangerschaftscholestase.
Abstraktband. 2004; -Jahrestagung der Österreichischen Gesellschaft für Dermatologie und Venerologie; DEC 3-5, 2004; Graz, AUSTRIA. [Poster]

 

Wagner, M; Fickert, P; Marschall, HU; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M Alternative exretory routes for accumulating bile acids via adaptive renal ABC transporter expression in common bile duct-ligated (CBDL) mice
GASTROENTEROLOGY. 2004; 126: A129-A130.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Gu, GL; Marschall, HU; Denk, H; Trauner, M Role of adaptive hepatobiliary transporter expression and regulation of bile acid synthetic enzymes in MDR2-/- mice: A model for chronic cholestatic liver disease due to sclerosing cholangitis
J HEPATOL. 2004; 40: 163-163.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90557-0
Web of Science FullText FullText_MUG

 

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Adaptive renal ABC transporter expression in common bile duct-ligated mice
J HEPATOL. 2004; 40: 26-26.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90073-6
Web of Science FullText FullText_MUG

 

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Hepatic and renal ABC transporter expression in mice depends on gender and changes in pregnancy
GASTROENTEROLOGY. 2004; 126: A130-A130.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Gender and pregnancy affect hepatic and renal ABC transporter expression in mice
J HEPATOL. 2004; 40: 94-94.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90307-8
Web of Science FullText FullText_MUG

 

Wagner, M; Halilbasic, E; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Denk, H; Trauner, M Nuclear receptor (PXR, CAR) agonists induce adaptive hepatic transporter and enzyme expression in mouse liver
J HEPATOL. 2004; 40: 25-25.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY. Doi: 10.1016/S0168-8278(04)90069-4
Web of Science FullText FullText_MUG

 

Wagner, M; Halilbasic, E; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Xenobiotic nuclear receptor (PXR, CAR) agonists coordinately stimulate a spectrum of detoxification enzymes and transport systems involved in the adaptive response to cholestasis in vivo.
HEPATOLOGY. 2004; 40: 489A-489A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

 

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel abc transporters, in mice
J HEPATOL. 2004; 40: 25-25. Doi: 10.1016/S0168-8278(04)90070-0
Web of Science FullText FullText_MUG

 

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Cholic acid (CA) and ursodeoxycholic acid (UDCA) exert different effects on hepatic and renal expression of Mrp4 and Mrp6, two novel ABC transporters
GASTROENTEROLOGY. 2004; 126: A16-A16.
Web of Science

 

Zollner, G; Wagner, M; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Guo, GL; Marschall, HU; Denk, H; Trauner, M Mdr2(-/-) mice with sclerosing cholangitis: A model of chronic cholestasis to study the role of the adaptive response of hepatobiliary transport systems and bile acid synthetic enzymes
GASTROENTEROLOGY. 2004; 126: A751-A751.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Zenz, R; Zsengeller, Z; Szabo, C; Denk, H Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cholestatic liver injury.
HEPATOLOGY 2003 38: 576A-576A.
Web of Science

 

Trauner, M; Fickert, P; Zollner, G; Zatloukal, K; Denk, H Acquired alterations of hepatobiliary transport systems in human cholestatic liver diseases: potential targets of pharmacotherapy
In: Paumgartner, G; Keppler, D; Leuschner, U; Stiehl, A editor(s).FALK SYMPOSIUM; BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY; MAY 30-JUN 01, 2002; FREIBURG, GERMANY. DORDRECHT: KLUWER ACADEMIC PUBL; 2003. p.163-177.

 

Wagner, M; Fickert, P; Fuchsbichler, A; Silbert, D; Gumhold, J; Zollner, G; Zatloukal, K; Marschall, HU; Schuetz, JD; Gonzalez, FJ; Denk, H; Trauner, M Hepatic and renal ABC transporter expression as critical determinants of ursodeoxycholic acid-induced bile infarcts in bile duct-ligated mice.
HEPATOLOGY 2003 38: 688A-689A.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Marschall, HU; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M The role of the bile acid receptor FXR in determining ATP-binding cassette (ABC) transporter expression and liver injury in common bile duct ligated (CBDL) mice
J HEPATOL 2003 38: 190-190. Doi: 10.1016/S0168-8278(03)80031-4
Web of Science FullText FullText_MUG

 

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Tsybrovskyy, O; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Role of nuclear bile acid receptor, FXR, in determining ATP-binding cassette (ABC) transporter expression and cholestatic liver injury in common bile duct-ligated mice
GASTROENTEROLOGY 2003 124: A697-A698. Doi: 10.1016/S0016-5085(03)83527-8
Web of Science FullText FullText_MUG

 

Zatloukal, K; Stumptner, C; Fuchsbichler, A; Fickert, P; Trauner, M; Denk, H The role of keratin in steatohepatitis.
HEPATOLOGY 2003 38: 501A-501A.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Guo, G; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M Role of nuclear bile salt receptors Fxr and Pxr in mediating adaptive hepatobiliary transporter response to cholic acid (CA) in mouse liver
GASTROENTEROLOGY 2003 124: A59-A59. Doi: 10.1016/S0016-5085(03)80292-5
Web of Science FullText FullText_MUG

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M Regulation of the Na+/taurocholate cotransporter Ntcp via short heterodimer partner (SHP)-dependent or SHP-independent mechanims depends on the type of cholestatic injury
GASTROENTEROLOGY 2003 124: A730-A730. Doi: 10.1016/S0016-5085(03)83688-0
Web of Science FullText FullText_MUG

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M Role of short heterodimer partner (SHP) -dependent and -independent pathways for regulation of Na+/taurocholate cotransporter (NTCP) expression in cholestatic mouse models.
J HEPATOL. 2003; 38(2):9-10.-38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; MAR 29-APR 01, 2003; ISTANBUL, TURKEY. Doi: 10.1016/S0168-8278(03)80442-7
Web of Science PubMed FullText FullText_MUG

 

Zollner, G; Fickert, P; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Zatloukal, K; Denk, H; Trauner, M Induction of intestinal multidrug resistance-associated proteins 2 and 3 (Mrp2, Mrp3) by cholic acid (CA) and ursodeoxycholic acid (UDCA) in mice.
HEPATOLOGY 2003 38: 689A-689A.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Stumptner, C; Neuberger, J; Zatloukal, K; Denk, H Abnormal expression and phosphorylation of cytokeratins in primary biliary cirrhosis (PBC).
J HEPATOL. 2002; 36(S1):141-141. Doi: 10.1016/S0168-8278(02)80506-2
Web of Science PubMed FullText FullText_MUG

 

Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Arbeiter, S; Gonzalez, F; Denk, H; Trauner, M Adaptive hepatic and renal transporter regulation in cholic acid (CA)-fed mice: Role of nuclear bile acid receptor (FXR).
HEPATOLOGY 2002 36: 454A-454A.
Web of Science

 

Zollner, G; Fickert, P; Arbeiter, S; Silbert, D; Fuchsbichler, A; Gonzalez, F; Zatloukal, K; Denk, H; Trauner, M Ursodeoxycholic acid (UDCA) feeding induces adaptive hepatic and renal ABC-transporter expression in mice.
HEPATOLOGY 2002 36: 454A-454A.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Stumptner, C; Neuberger, J; Zatloukal, K; Denk, H; Trauner, M Alterations of hepatobiliary transporter expression in primary biliary cirrhosis (PBC)
J HEPATOL 2002 36: 28-29. Doi: 10.1016/S0168-8278(02)80086-1
Web of Science FullText FullText_MUG

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Messenger RNA expression of nuclear, orphan receptors and hepatocyte nuclear factor 1 alpha (HNF-1 alpha) in inflammation-associated cholestasis (IC) and primary biliary cirrhosis
HEPATOLOGY 2002 36: 454A-454A.
Web of Science

 

Fickert, P; Fuchsbichler, A; Zollner, G; Stumptner, C; Weiglein, A; Zatloukal, K; Denk, H; Trauner, M Mdr2-p-glycoprotein-deficient (Mdr2-/-) mouse - A new model for primary sclerosing cholangitis (PSC)?
HEPATOLOGY 2001 34: 509A-509A.
Web of Science

 

Fickert, P; Zollner, G; Fuchsbichler, A; Stumptner, C; Lammert, F; Zaltloukal, K; Denk, H; Trauner, M Ursodeoxycholic acid (UDCA) feeding aggravates liver injury in bile duct-ligated and Mdr2 kockout mice
J HEPATOL 2001 34: 182-182.
Web of Science

 

Fickert, P; Zollner, G; Fuchsbichler, A; Stumptner, C; Lammert, F; Zatloukal, K; Denk, H; Trauner, M Ursodeoxycholic acid feeding aggravates liver injury in bile duct-ligated mice
GASTROENTEROLOGY 2001 120: A1-A1.
Web of Science

 

Trauner, M; Fickert, P; Zollner, G; Stauber, RE; Krejs, GJ Molecular basis of bile formation and cholestasis
In: Acalovschi, M; Paumgartner, G editor(s).FALK SYMPOSIUM; HEPATOBILIARY DISEASES: CHOLESTASIS AND GALLSTONES; JUN 09-10, 2000; CLUJ-NAPOCA, ROMANIA. DORDRECHT: KLUWER ACADEMIC PUBL; 2001. p.3-20.

 

Zollner, G; Fickert, P; Fuchsbichler, A; Stumptner, C; Denk, H; Zatloukal, K; Ferenci, P; Trauner, M Expression of multidrug resistance P-glycoproteins (MDRs) and multidrug resistance-associated proteins (MRPs) in Wilson disease (WD)
J HEPATOL 2001 34: 188-188.
Web of Science

 

Zollner, G; Fickert, P; Fuchsbichler, A; Stumptner, C; Denk, H; Zatloukal, K; Trauner, M Multidrug resistance P-glycoproteins (MDR) and multidrug resistance-associated proteins (MRP) are not overexpressed in human hepatocellular carcinomas (HCC).
J HEPATOL 2001 34: 189-189.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Stumptner, C; Ott, P; Zatloukal, K; Denk, H; Trauner, M Expression of multidrug resistance p-glycoproteins (MDR), multidrug resistance-associated proteins (MRP) and bile acid transporters in human hepatocellular carcinomas (HCC).
HEPATOLOGY 2001 34: 665A-665A.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M; Franzens, K Induction of the transcriptional repressor short heterodimer partner 1 precedes down-regulation of the Na+/taurocholate cotransporter in bile duct-ligated mice.
HEPATOLOGY 2001 34: 469A-469A.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H Toxic bile acids induce cytokeratin 8/18 overexpression and hyperphosphorylation in mouse liver.
GASTROENTEROLOGY 2000 118: 3726-3726. Doi: 10.1016/S0016-5085(00)86223-X
Web of Science FullText FullText_MUG

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H Cytokeratin 8/18 overexpression and hyperphosphorylation induced by toxic bile acids in mouse liver
J HEPATOL 2000 32: 76-76. Doi: 10.1016/S0168-8278(00)80623-6
Web of Science FullText FullText_MUG

 

Fickert, P; Zenz, R; Zoliner, G; Pojer, C; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Role of bile acid hydrophobicity in regulation of hepatocellular transporter expression in mice
J HEPATOL. 2000; 32(1 Su):39-39. Doi: 10.1016/S0168-8278(00)80479-1
Web of Science FullText FullText_MUG

 

Fickert, P; Zenz, R; Zollner, G; Pojer, C; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Regulation of hepatocellular transporter expression depends on bile acid hydrophobicity in mice.
GASTROENTEROLOGY 2000 118: 168-168. Doi: 10.1016/S0016-5085(00)85876-X
Web of Science FullText FullText_MUG

 

Schreiber, F; Eherer, AJ; Trauner, M; Schnedl, W; Gurakuqi, GC; Krojs, GJ Self expanding metallic stents in malignant enteral obstruction - Early experiences with a new palliative treatment.
GASTROINTEST ENDOSCOP 2000 51: 3496-3496. Doi: 10.1016/S0016-5107(00)14196-3
Web of Science FullText FullText_MUG

 

Stauber, RE; Hegenbarth, KS; Maurer, U; Kroisel, PM; Fickert, P; Trauner, M No evidence for teratogenic effects of ribavirin: Report of two cases.
HEPATOLOGY 2000 32: 1639-1639.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Kenner, L; Zatloukal, K; Denk, H Role of Kupffer cells in hepatocellular cytokeratin 8/18 expression in lipopoly-saccharide or DDC-induced hepatic injury.
HEPATOLOGY 1999 30: 552A-552A.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zatloukal, K; Denk, H Cholestasis and bile acid feeding induce cytokeratin 8/18 expression and mallory body formation in mice.
HEPATOLOGY 1999 30: 464A-464A.
Web of Science

 

Trauner, M; Fickert, F; Zenz, R; Pojer, C; Fuchsbichler, A; Zollner, G; Denk, H; Zatloukal, K Role of Kupffer cells in regulation of multidrug resistance (mdr) P-glycoprotein expression in intrahepatic and obstructive cholestasis.
HEPATOLOGY 1999 30: 463A-463A.
Web of Science

 

Trauner, M; Zenz, R; Fickert, P; Kenner, L; Stauber, RE; Denk, H; Zatloukal, K Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis.
HEPATOLOGY 1999 30: 467A-467A.
Web of Science

 

Kenner, L; Stumptner, C; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Tau overexpression in human alcoholic liver disease.
HEPATOLOGY 1998 28: 512A-512A.
Web of Science

 

Kenner, L; Trauner, M; Fickert, P; Stauber, RE; Eferl, R; Denk, H; Zatloukal, K Overexpression of keratin-8 and -18 RNA associated with mallory body formation in patients with alcoholic hepatitis.
HEPATOLOGY 1998 28: 303A-303A.
Web of Science

 

Lee, JM; Trauner, M; Soroka, CJ; Steiger, B; Meier, PJ; Boyer, JL The molecular expression of the bile salt excretory pump, sister of P-glycoprotein (spgp), is selectively preserved in cholestatic liver injury.
HEPATOLOGY 1998 28: 429A-429A.
Web of Science

 

Schreiber, F; Gurakuqi, GCH; Trauner, M; Schnedl, W; Krejs, GJ Self expanding metallic stents in malignant colonic obstruction - Early experiences with a new palliative treatment
GASTROINTEST ENDOSCOP 1998 47: AB104-AB104.
Web of Science

 

Stauber, RE; Trauner, M; Fickert, P Soreness of mucosal membranes in patients receiving interferon-alpha plus ribavirin for treatment of chronic hepatitis C.
HEPATOLOGY 1998 28: 704A-704A.
Web of Science

 

Trauner, M; Mennone, A; Gigliozzi, A; Fraioli, F; Boyer, JL Nitric oxide (NO) and guanosine 3 ',5 '-cyclic monophosphate (cGMP) stimulate bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units.
HEPATOLOGY 1998 28: 531A-531A.
Web of Science

 

Arrese, M; Trauner, M; Ananthanarayanan, M; Boyer, JL; Suchy, FJ Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide
GASTROENTEROLOGY 1997 112: A1215-A1215.
Web of Science

 

Arrese, M; Trauner, M; Ananthanarayanan, M; Koeppel, T; Boyer, JL; Suchy, FJ Adaptive regulation of bile salt transport in experimental diabetes: Role of basolateral and canalicular transporters.
HEPATOLOGY 1997 26: 653-653.
Web of Science

 

Arrese, M; Trauner, M; Goldberg, DI; Crossman, M; Shneider, BL Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression or function of the rat ileal bile acid transporter
HEPATOLOGY 1997 26: 654-654.
Web of Science

 

Koeppel, TA; Trauner, M; Baas, JC; Thies, JC; Schlosser, SF; Post, S; Boyer, JL; Otto, G Impairment of the hepatic microcirculation in the bile duct ligated rat.
GASTROENTEROLOGY 1997 112: A1306-A1306.
Web of Science

 

Koeppel, TA; Trauner, M; Mennone, A; Arrese, M; Boyer, JL Glutathione is a driving force for hepatic bile formation following cold ischemia of the rat liver
HEPATOLOGY 1997 26: 144-144.
Web of Science

 

Trauner, M; Arrese, M; Lee, HR; Boyer, JL; Karpen, SJ Endotoxin-induced down-regulation of the rat liver Na+/taurocholate cotransporter (ntcp) gene is mediated by decreased activity of hepatocyte nuclear factor 1 (HNF 1).
HEPATOLOGY 1997 26: 535-535.
Web of Science

 

Arrese, M; Ananthanarayanan, M; Trauner, M; Boyer, JL; Suchy, FJ Effect of pregnancy on mRNA expression of liver transporters.
HEPATOLOGY 1996 24: 353-353.
Web of Science

 

F. Schreiber F, Gurakuqi G, Trauner M. A New Approach to the Difficult Common Bile Duct Stone. Our Experiences with the Stone Recognition Laser System.
Vortrag am 91. Falk Symposion; Februar 1996; Hongkong.. 1996. [Keynote lecture]

 

F Schreiber, GCH Gurakuqi, M Trauner, GJ Krejs. Intracorporeal Laser Lithotripsy with a Stone Recognition Pulsed Dye Laser System. Poster und Vortrag
Falk Conference Report1996; -Falk Symposion No. 90 ; Feb. 29th - March 1st 1996.; Hongkong,. [Oral Communication]

 

Gartung, C; Trauner, M; Schlosser, SF; Hagenbuch, B; Meier, PJ; Boyer, JL Sodium-independent uptake of bile acids is unaffected by down-regulation of an organic anion transporter (oatp) in rat liver during cholestasis produced by common bile duct ligation (CBDL).
HEPATOLOGY 1996 24: 970-970.
Web of Science

 

Gartung, C; Trauner, M; Schuele, S; Boyer, JL Role of TNF-alpha steroids and estrogens in the regulation of the Na+/taurocholate cotransporter (ntcp) in rat liver during the early phase of extrahepatic cholestasis.
HEPATOLOGY 1996 24: 971-971.
Web of Science

 

Trauner, M; Ananthanarayanan, M; Yi, JR; Arrese, M; Kaplowitz, N; Boyer, JL Effects of endotoxin on the expression of the canalicular glutathione (GSH) and multispecific organic anion transporters (cMOAT) in rat liver
HEPATOLOGY 1996 24: 359-359.
Web of Science

 

Trauner, M; Gartung, C; Schlosser, SF; Boyer, JL Role of nitric oxide in the transcriptional regulation of bile acid transporters in endotoxin - Induced cholestasis.
GASTROENTEROLOGY 1996 110: A1349-A1349.
Web of Science

 

Trauner, M; Mennone, A; Nathanson, MH; Boyer, JL Nitric oxide stimulates bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units.
J INVEST MED 1996 44: A301-A301.
Web of Science

 

SCHREIBER, F; GURAKUQI, GCH; TRAUNER, M ENDOSCOPIC INTRACORPOREAL LASER LITHOTRIPSY WITH A STONE RECOGNITION PULSED DYE-LASER SYSTEM - A NEW APPROACH TO DIFFICULT COMMON BILE-DUCT STONES
GASTROENTEROLOGY 1995 108: A435-A435. Doi: 10.1016/0016-5085(95)26054-4
Web of Science FullText FullText_MUG

 

TRAUNER, M; NATHANSON, MH; MENNONE, A; RYDBERG, SA; BRUCK, R; BOYER, JL NITRIC-OXIDE STIMULATES BILE-FLOW AND GLUTATHIONE EXCRETION INDEPENDENT OF CYCLIC-GMP-INDUCED HCO3- EXCRETION
HEPATOLOGY 1995 22: 834-834.
Web of Science

 

TRAUNER, M; NATHANSON, MH; RYDBERG, SA; GARTUNG, C; SESSA, WC; BOYER, JL NITRIC-OXIDE - INDUCED CHOLERESIS IS IMPAIRED IN ISOLATED-PERFUSED LIVERS OF ENDOTOXEMIC RATS
HEPATOLOGY 1995 22: 836-836.
Web of Science

 

HEINEMANN, A; TRAUNER, MH; STAUBER, RE NADOLOL INCREASES WHEREAS PROPRANOLOL REDUCES RESISTANCE IN MESENTERIC ARTERIAL BEDS OF RATS
GASTROENTEROLOGY. 1994; 106(4): A905-A905.
Web of Science

 

STAUBER, RE; TRAUNER, MH; HAUSEGGER, K; PETRITSCH, W IMPROVEMENT OF LIVER-FUNCTION AFTER TRANSJUGULAR INTRAHEPATIC PORTASYSTEMIC SHUNT (TIPS) IN A PATIENT WITH CHRONIC BUDD-CHIARI SYNDROME
HEPATOLOGY. 1993; 18(4): A344-A344. Doi: 10.1016/0270-9139(93)92899-B
Web of Science FullText FullText_MUG

 

TRAUNER, MH; HEINEMANN, A; STAUBER, RE EFFECT OF PROPRANOLOL ON PRESSOR-RESPONSES TO NOREPINEPHRINE IN MESENTERIC ARTERIAL BEDS OF NORMAL AND PORTAL HYPERTENSIVE RATS
HEPATOLOGY. 1993; 18(4): A287-A287. Doi: 10.1016/0270-9139(93)92672-M
Web of Science FullText FullText_MUG

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint